Final results for the year ended 31 December 2023

30 May 2024, 07:00

Source - LSE Regulatory

RNS Number : 3591Q

Helios Underwriting Plc

30 May 2024

30^th May 2024

Helios Underwriting plc

Final results for the year ended 31 December 2023

Significant rise in profits and distributions driven by outstanding Lloyd's market conditions

Helios Underwriting ('Helios' or the 'Company'), the only publicly traded investment company offering instant access to a diverse portfolio at Lloyd's of London, the world's largest insurance market, is pleased to announce its audited financial results for the year ended 31 December 2023.

Helios has positioned itself to maximise growth opportunities by doubling the size of its capacity portfolio over the last two years to £507 million for 2024, as the market experiences outstanding financial performance underpinned by strong pricing and underwriting discipline.

Full year 2023: key financial highlights

• Gross premium written increased by 26% to £308m (2022:£244m)

• Capacity portfolio at Lloyd's of £507m, up 63% (2022: £311m)

• Capacity portfolio combined ratio of 86% 2022 (2022: 96%)

• Profit before tax of £22.7m (2022 - loss of £3.9m)

• £18m profit from the revaluation of capacity (2022: £2.7m)

• Total comprehensive profit of £29.9m (2022: loss of £0.1m)

• 25% increase in net tangible asset value at £1.89p per share (2022: £1.51p)

• Issue of $75m Unsecured Loan Notes with a rating of A- by KBRA

• Earnings per share 22p (2022 - Loss (3.08)p)

• Dividend and total return of capital of 19p (2022: 3p) of which a base cash dividend of 6p will be paid

Chief Executive, Martin Reith, commented:

"Helios is the smartest way to invest at Lloyd's of London and the excellent 2023 financial performance reflects the strength of our unique proposition, our continued strategic delivery and some of the best underwriting conditions the market has experienced in a generation.

"We have focused on growing scale and relevance to ensure we maximise these market opportunities: we have grown by 63% in the past year alone, across all parts of the portfolio and through increased fee income. We continue to actively seek out new opportunities to expand our presence by supporting the best management teams and new ventures at Lloyd's where our capacity, insights and experience add real value.

"Lloyd's is the home of insurance innovation, providing solutions for many of the world's most pressing issues - from climate change, to the energy transition, and cyber risks. I'm proud of the way Helios has developed into a key partner for syndicates at Lloyd's and the pre-eminent provider of private capital into the market.

"Looking ahead I am excited by further unlocking the potential of Helios and I am confident in our ability to capitalise on the market opportunities and continue to offer uncorrelated returns by generating long-term growth and regular income for our investors."

For more information, please contact:

Helios Underwriting plc

Martin Reith (Chief Executive)

Arthur Manners (Chief Financial Officer)

+44 (0)203 965 6441

FTI Consulting

Ed Berry

Nathan Hambrook-Skinner

Tom O'Brien

+44 (0)7703330199

+44 (0)7977817092

+44 (0)7929021492

Helios Underwriting plc

Preliminary results for the year ended 2023

Chairman's statement

Improved rating delivers improved profitability

"We are confident that the Helios portfolio will deliver value to shareholders."

Michael Wade

Non-executive Chairman

£22.7m

Profit before tax - £22.7m (2022: loss of £3.9m)

£18m

Gain on revaluation capacity £18m (2022: £2.7m)

£29.9m

Total comprehensive profit of £29.9m (2022 loss: £0.1m)

£1.89

Net asset value at £1.89 per share (2022: £1.51)

19p

Return of capital in 2023 and 2024 expected to be
19p per share

A final dividend of 6p per share is being recommended (2022: 3p)

Growth in retained capacity.

132% CAGR

2024 392

2023 245

2022 178

2021 99

In summary

• Gross premium written increased by 26% to £308m

• Profit before tax of £22.7m - (2022: loss of £3.9m)

• Profit from the revaluation of capacity £18.0m - (2022: profit of £2.7m)

• Total comprehensive profit of £29.9m (2022: loss of £0.1m)

• 25% increase in net tangible asset value at £1.89 per share (2022: £1.51)

• Capacity portfolio combined ratio of 86%

• Earnings per share 22p

• Dividend and total return of capital of 19p of which a base cash dividend of 6p will be paid (2022: 3p)

I am delighted to be able to report a significant improvement in the profitability of the Company as the growth in the retained capacity over the last three years has started to deliver the expected profitability and growth in shareholder value.

The Lloyd's market has continued to regain its strength and profitability; these results are the beginning of a period where we can see attractive pipeline returns derived from our spread portfolio of syndicate participations through ownership of subsidiary corporate members of Lloyd's.

The net asset value ("NAV") of the Company has grown from a combination of underwriting profitability, investment income returns and the increasing value of the Lloyd's syndicate portfolio where we have capacity value and pre-emption rights.

Return of Capital

The Company is committed to returning capital to its shareholders and does so by way of dividends and share buy-backs. In 2023 a total of £5.5m was returned to shareholders comprising a base dividend of 3p per share (£2.3m) and the buying back of 2.24m shares, for a total consideration of £3.2m in 2023 at an average price that has been accretive to net asset value per share.

In 2024, the Board is proposing to further enhance capital returns to shareholders. A base dividend of 6p per share (£4.5m) is proposed together with a further buy back of shares of value up to £3.7m by 31 December 2024. This, alongside the £1m in share-buyback already completed, will result in the total capital returned to shareholders in 2024 being up to £9.0m.

The aggregate capital returned to shareholder in 2023 and 2024 is expected to be up to £14.5m - 19p per share.

This return of capital reflects the Board's confidence in future cash flow and the prospects for profitable underwriting. The Board believes that the illiquidity in the Company's shares can create significant volatility in the share price and some liquidity provided by the Company through share buybacks will assist in managing trading in the shares.

There will be the option to take new ordinary shares in lieu of the base dividend.

Capacity Portfolio

The information on the capacity portfolio will enable analysts to estimate pipeline profits from the 2022 and 2023 Lloyd's underwriting year of accounts within the notes to the accounts. We anticipate attractive results receivable in the 2025 and 2026 calendar years.

As we commence 2024, shareholders should be encouraged to note, as explained further in our Chief Executive's Report, Helios now manages over £500m of the Capacity Portfolio across 40 syndicates, of which 77% is retained for our shareholders and 23% acting for third party capital providers and where Helios will generate fees and commissions.

The freehold capacity on well-established syndicates at Lloyd's continues to form the cornerstone of the capacity portfolio. When these syndicates wish to grow their businesses, the existing owners of the capacity have pre-emptive rights to receive additional capacity pro rata to the scale of increase in the underlying business. The additional capacity is free of acquisition cost and the value of this additional capacity increases our asset valuation, albeit requiring additional capital to meet Funds at Lloyd's. During 2023, the value of the capacity fund increased by 32% from the free capacity offered from pre-emptions, from capacity acquired with the acquisition of LLVs and from an increase in the average prices traded at the Lloyd's auctions in 2023.

Helios actively manages capital. We have a number of strategic options we can turn to increase or decrease our exposure. Fee income remains an attractive earnings stream which complements our underwriting returns. For the 2024 Year of Account we launched a "sidecar" facility for third party capital that can access the Helios Capacity Portfolio. As the market cycle evolves, we evaluate opportunities to maintain underwriting exposure and cede risk for fees.

Performance

It is important to understand that there is a three-year delay in the realisation of underwriting profits in our accounts so at the moment we are benefiting from the profits realised from the 2021 and 2022 underwriting years. In addition, the benign catastrophe year in 2023 has allowed the 2023 Year of Account to recognise an underwriting profit at 12 months of £7.7m (2022: loss of £9.5m), which has contributed to the overall result.

The results for the year ended 31 December 2023 show an operating profit for the year of £22.7m (2022: loss of £3.9m) and total comprehensive income of £29.9m The net asset value of the Group is £1.89 per share (2022: £1.51).

Summary financial information

	Year to 31 December
	2023 £'000	2022 £'000
Gross written premium	307,770	244,614
Net earned premium	200,980	150,393
Underwriting profits	31,560	116
Other income	4,130	2,458
Total costs	(12,986)	(6,527)
Profit before Tax	22,705	(3,953)
Revaluation of syndicate capacity	17,987	2,670
Tax	(10,831)	1,184
Total comprehensive income	29,861	(99)
Earnings per share	21.56p	(3.08)p
NTAV - £ per share	1.89	1.51

During 2023, the opportunity to raise long-term debt and raised $75m with a seven-year term and a fixed coupon of 9.5% (currently a net cost of approximately £5.7m per annum). This additional finance allowed us to re-finance some existing bank Funds at Lloyd's facilities and it further assists in matching our asset base to the underlying insurance exposures which are mainly in US dollars. We would expect that this additional finance will be lodged as funds at Lloyd's to support underwriting in the future.

Board Changes

My sincere thanks to my predecessor Michael Cunningham for his wise custodianship of the Helios Board and assisting me to take over as your Chairman last June. In addition to the retirement of Michael Cunningham, the Duke of Norfolk left the Board in April and we thank him for his service and independent counsel. We have appointed a specialist search firm to assist us in bringing two new independent Non-executive Directors where there are skill sets of risk and audit respectively.

Future prospects

We envisage further opportunities during 2024 and into 2025 and will position the portfolio accordingly. We expect the majority of the syndicates we support to pre-empt in order to benefit from the attractive rating environment and market discipline. In addition, we are evaluating new opportunities for Helios that will give shareholders further diversification. It is our hope that, with these prospects, the AIM stock market will value more appropriately and attract better liquidity for our shares.

Michael Wade

Non-executive Chairman

29 May 2024

Chief Executive Officer's review

Helios has evolved into a hard hitting preferred capital provider at Lloyd's

"Substantial increase in profitability and the growth in the capacity portfolio driving value"

Martin Reith

Chief Executive Officer

£42.7m

Portfolio underwriting result of £42.7m (2022: £2.0m)

£29.9m

Total comprehensive income £29.9m (2022: loss of £0.1m)

£1.89

Net asset value £1.89 (2022: £1.51)

25%

Growth in Net Asset value

34%

Growth in net earned premium (2022: 117%)

86%

Combined ratio for the overall portfolio

Operating profit

• Capacity Portfolio £507m

• Revaluation of Capacity - Gain of £18m

• Dividend per share - 6p

• Return of capital per share 19p

• Debt raise $75m

• Earnings Per Share 22p

• Net Tangible assets £140m/GWP £308m

The Lloyd's insurance market is experiencing the most attractive underwriting conditions for a generation with record profits for 2023 driven by disciplined underwriting and investment returns. The market reported a net combined ratio of 84%, £5.2bn investment returns and delivering profits of £10.7bn. The market has witnessed significant premium growth from pricing correction and new opportunities and for 2024; the expectation is to write £60bn, up 11% from 2023.

In an increasingly challenging global environment - politically, environmentally and fiscally - we continue to scrutinise and assess likely impacts and adjust our stance accordingly. The market is still in the grip of a peril from Russia's invasion of Ukraine and Israel's' continuing military action in Gaza. Casualty reserves and adequacy remain a concern with rising inflation, albeit mitigated to some extent by the rise in interest rates.

The market continues to focus on becoming more efficient with a steadfast focus on underwriting discipline and increased adoption of digitalisation. The arrival of technology, enriching the underwriting process, will create new opportunities to evaluate more risks faster and more efficiently. As technology enhances and enriches the process of underwriting risks at Lloyd's, this could create an opportunity to further increase participation in the future. The bifurcation of the lead/follow will create new opportunities where we expect to benefit across our portfolio.

Changes in 2024 planned capacity by 2022 combined ratio quartile (%)

Helios Lloyd's

First quartile

52%

Second quartile

44%

(5%)

Third quartile

49%

Fourth quartile

15%

13%

2024 Capacity by 2022 Quartile

First Quartile, 24%

Second Quartile, 26%

Third Quartile, 13%

Fourth Quartile, 17%

New, 20%

Once again, Helios has sought to position the portfolio to maximise market opportunities. Market discipline and pricing adequacy remains strong and the capacity portfolio has doubled over the past two years and stands at £507m for 2024. Our portfolio, increasingly diversified and volatility managed, is seeing growth across all sectors of the portfolio.

Overall, we have grown by 63% from 2023 in to 2024, increasing our retained position and growing our fee earning aspect with third party capital. Our strategy is to manage a diversified portfolio of underwriting capacity. During this year, the Helios-retained capacity has grown from £245m to £392m, a 60% increase. We have built our portfolio across the 4 quartiles as illustrated in the chart above. Helios has increased the proportion of capacity in each of the top three Lloyd's quartiles by over 40%. This growth rate is significantly higher than that of the entire Lloyd's market.

There is little doubt that our impact and relevance is growing in the market. We are often approached to support new syndicates and lead their funds at Lloyd's placement. We have been able to grow beyond the pre-emption amounts in some occasions, benefiting from our market-wide relationships.

Our analytical skills continue to grow as we interrogate our portfolio using data and analytics to ensure balance, capital management and curation. Since the last report, I am delighted to welcome Jen Tan as our Head of Portfolio Strategy, Michelle Faithful as our syndicate and portfolio analyst and our new Chief Operating Officer, Adhiraj Maitra. These are significant developments that will position us well to develop our cycle managed strategies.

You will see later in this report some greater granularity around our portfolio characteristics.

As we look forward, we shall continue to tailor the portfolio, using data and analytics, to optimise opportunities mindful of market conditions and origination opportunities. We are in active discussions with Lloyd's to ensure we are in tune with the market's ambitions, views and strategies as we seek opportunities to optimise the portfolio and to access the market beyond the current capacity portfolio.

We have evolved to become a hard-hitting preferred Funds at Lloyd's capital provider deploying significant capacity and capital on opportunities that meet or exceed our return requirements. We try to be innovative and creative, working with our portfolio to determine new ways to build our relationships and relevance. At the heart of what we do is supporting extraordinary Executives across management and underwriting. They are the ones that build and drive their businesses and Helios supports them in that quest with access to knowledgeable committed capital.

Our share price performance remains disappointing and not reflective of the Company's performance. It is clear we need to sharpen our messaging and communication to ensure that our various stakeholders and audiences understand our value proposition.

The Board is committed to returning capital to shareholders and we are confident that we shall be able to make significant strides in this respect.

Helios punches above its weight given the staff numbers and impact. My sincere thanks to the Helios team for all their hard work and welcome to those new joiners.

Martin Reith

Chief Executive Officer

29 May 2024

Portfolio Management report

Introduction

While we continue to work closely with our Members Agents, the growth of the Company, in particular the Portfolio Management function, has allowed us to develop in-house analytical capabilities.

Our portfolio management and strategy is rooted in a rigorous interrogation process for syndicate selection. This involves a thorough examination of multiple aspects for every syndicate in our portfolio. We review business plans in detail, evaluating every aspect from financial projections to strategic directions. We also use different data and analytical tools (e.g. stress and scenario tests) to evaluate the impact of a syndicate's potential impact on the overall portfolio and make informed decisions. This is an evolving process and we are looking to introduce stochastic modelling techniques in the business as usual evaluation process.

We aim to optimise and diversify the portfolio, ensuring we have a balanced mix of syndicates capable of withstanding market losses and with the intention of providing consistent superior performance.

The final decision to include a syndicate in our portfolio rests with the Board, ensuring accountability and alignment with our overall strategy.

We actively monitor performance and adjust our strategies as necessary, tailoring our portfolio in response to market conditions and pricing.

Overview of our portfolio

The Capacity Portfolio is positioned to maximise underwriting returns, and take advantage of favourable market conditions we are enjoying in 2023 and beyond. There has been increased focus and curation from the 2022 to 2023 portfolio with an emphasis on:

• managing exposure to natural catastrophe;

• growth into specialty lines;

• targeting risks, classes and geographies that diversify the portfolio;

• building relationships with syndicates that attract non-correlating exposure; and

• identifying new relationship capacity with excellent growth prospects.

The chart below is an illustration of the process followed in reviewing new opportunities for the Helios Capacity Portfolio.

Evaluation process

Initial review

• Submission review

• Meetings with syndicate and brokers

• Q&A sessions

Syndicate deep dive

• Business plan review

• Historical performance analysis

• Capital modelling

• Syndicate scoring

• Performance and volatility modelling

Portfolio impact

• Financial projection

• Portfolio mix

• Large loss exposure

• Aggregation / Diversification

• Stress testing

• Portfolio modelling

Decision making

• Recommendation presented to the Portfolio Management Committee

• Decision approved by the CEO and Board

2024 Portfolio Review

Helios' capacity portfolio has grown from £311m for 2023 year of account ("YOA") to £507m for 2024 YOA. This 63% increase has been achieved through growth beyond pre-emptions in several syndicates, cementing that demand and desire to have Helios capital.

The addition of eight new syndicates has generated further diversification on the portfolio and an increase in classes of business and expansion into geographical areas where we historically had limited exposure.

We actively seek out new, niche and high-quality syndicates that may become difficult to access in the future.

Freehold syndicates - Participations in syndicates managed by these managing agents represent shares in the long-established businesses at Lloyd's. We strive to acquire LLVs with portfolios that comprise these quality syndicates, thereby having to pay the average auction prices to get access. This proportion of the portfolio provides diversified exposure to syndicates that have experienced underwriting teams and well-established portfolios where each management team allocates capital to the business areas with the better risk adjusted returns.

Number of syndicates

Established New

2022 25 3 28

2023 27 5 32

2024 30 10 40

Growth in capacity £m

Retained capacity Third party capacity

2022 182 63 245

2023 245 66 311

2024 392 115 507

Tenancy syndicates - We have a mix of longstanding relationship capacity and syndicates that we are supporting for the first time. In reality, while we hope to have secured capacity over the long term, we need to renew for each YOA and that adds to our overall portfolio construction.

Curation of the portfolio

The table shows the movement in the portfolio to position for the 2024 year of account. The portfolio has been actively managed during the year to achieve the following:

	Freehold capacity	Tenancy capacity	Total capacity
2023 YOA capacity	147.3	155.5	310.8
Acquisitions	7.4	0.7	8.1
Pre-emptions	14.7	27.1	41.8
New syndicates	-	100.8	100.8
Auction - buy	6.5	-	6.5
Portfolio management	-	55.8	55.8
Discarded capacity	-	(8.6)	(8.6)
2024 YOA capacity	175.9	331.2	507.1
% increase	19%	113%	63%

Pre-emptions - £41.8m - the syndicates supported grew their businesses on average by 13% for the 2024 year of account and we took up these pre-emptions for no cost.

New syndicates - We have been active in supporting leading management teams wanting to take advantage of the Lloyd's licences and infrastructure to start new syndicates that either have a unique proposition or will be underwriting existing portfolios with a profitable track record. It is essential for the new opportunities to have strategic alignment with the Helios Capacity Portfolio, increase diversification and meet our risk appetite requirements.

Details of some of the syndicates (new and established) added to our portfolio are outlined below.

We invested in Wildfire Defense Syndicate 1996 (WDS). This new Syndicate in a Box focuses on loss prevention and is committed to reducing wildfire losses across the insurance industry focusing initially on California. The WDS's response actions on properties threatened by wildfires lead to significant savings. It prevents structures from being lost to wildfires, which in turn reduces carbon emissions from structure combustion and reconstruction.

Nephila 2358, two new Special Purpose Arrangements (Envelop 1925 and AdA 1492) and two Syndicates in a Box (Volante 2358 and Parsyl 1796) were also added to our portfolio in 2023.

In 2024, we provided further capital support to four new Syndicates in a Box with different and uncorrelated risk profiles.

We made a strategic investment by providing capital to MCI Syndicate 1966, an innovative venture that was officially launched in April of 2024.

Syndicate 1966 is unique in that it introduces a revolutionary new product that offers insurance for clinical trial funding, specifically designed for the rapidly growing biotechnology industry. This product is not just an insurance policy, it is a tool that has the potential to greatly impact the future of medical research and development.

The syndicate leverages advanced technology, employing an Artificial Intelligence (AI) model, to predict the success rate of clinical trials. This predictive model is a key aspect of their business strategy, as it allows for more accurate and efficient allocation of resources. By doing so, Syndicate 1966 not only mitigates risks but also actively promotes medical innovation.

The other three new additions, namely NormanMax 3939, Agile 2427 and African Specialty Risk 2454 (ASR), have all demonstrated a consistent proven track record of profitability through their MGA historical performance.

NormanMax offers a unique parametric product that is light on our portfolio.

On the other hand, Agile predominantly underwrite Australian and New Zealand risks.

ASR specialises in insuring African countries. These geographic focuses brings a level of diversification to our portfolio, as it strays from more common regions of our existing portfolio.

Therefore, these syndicates are expected to not only contribute positively to our bottom line but also bring about strategic advantages in terms of portfolio diversification.

Auction - buy - £6.5m - we again took advantage of lower-than-expected prices on certain syndicates to purchase additional capacity. These syndicates have good prospects in the future, particularly for gains on the price on capacity rights.

Acquisitions - £8.1m - the capacity acquired supplemented the existing freehold capacity participations.

Portfolio management - £55.8m - Helios leveraged its strong relationships with the syndicates it supports to increase participation in several high-performing syndicates, beyond pre-emptions, in order to benefit from favourable market conditions.

Discarded capacity - £8.6m - as part of the portfolio evaluation and monitoring, we reduced our participations on specific syndicates to aid the balance and contributions across the portfolio.

Declined opportunities: We have seen and declined a number of opportunities where we are unconvinced of the strategic direction, projected financial performance or scope of cover.

Mix of syndicates

Helios is a true spread vehicle with a portfolio across 40 syndicates. Among these, 63% are established syndicates (>three years of underwriting); 22% have less than three years of operating experience and 15% are new syndicates which commenced business operations in 2024.

The number of new syndicates supported in 2024 increased as Helios looked to optimise in the current strong market. Helios is presented with many new opportunities; each of these are thoroughly evaluated and analysed before any support decisions are made. We have declined opportunities which are not aligned with the Company's strategic objectives for the portfolio and cautiously allocate small capacity support on new syndicates.

Beazley 623, 32.7m

TMK 510, 30.3m

Apollo 1969, 25.5m

Arch 1955, 20.0m

Atrium 609, 19.5m

Hiscox 33, 15.4m

Beat 4242,15.0m

Agile 2427, 15.0m

MCI 1902, 12.6m

Dale 1729, 25.1m

Flux 1985, 20.0m

ERS 218,17.7m

CFC 1988, 15.1m

Envelop 1925, 12.5m

WDS 1996, 9.5m

ADA 1492, 8.5m

Lancashire 2010 7.3m

Blenheim 5886, 30.8m

NormanMax 3939, 12.0m

Parsyl 1796, 7.0m

Other participations totalling 36.2m

Beazley 5623, 27.0m

Apollo 1971, 25.0m

Nephila 2358, 20.0m

MAPL 2791, 16.4m

MCI 2 CTF, 15.0m

Hiscox 6104, 10.0m

ASR, 5.8m

Financial analysis

Portfolio underwriting result

The portfolio achieved a net combined ratio of 86% in comparison with the combined ratio for the Lloyd's market of 84%. The portfolio's combined ratio is affected by the early earning development of new syndicates and their inherently cautious loss ratios. However, if we exclude the new syndicates, the established ones within the portfolio align with the market. Over time, as these new syndicates mature and their earnings grow, we expect the associated combined ratios to improve.

Established syndicate, 63%

Less than three years, 22%

New, 15%

2023 Helios calendar year net combined ratio analysis	Total	New syndicates	Established syndicates	Freehold	Tenancy
Capacity %		11.2%	88.8%	62.3%	37.7%
Net claims ratio	49.4%	55.1%	48.9%	48.1%	51.4%
Acquisition cost ratio	25.8%	25.4%	25.9%	26.6%	24.6%
Expenses ratio	10.6%	16.6%	10.0%	11.2%	9.7%
Net combined ratio (NCOR)	85.8%	97.1%	84.8%	85.9%	85.6%
Result £m*	42.7	1.1	41.6	28.2	14.5

* Before Helios reinsurance and expenses.

Portfolio underwriting result

The contribution from the 2021,2022 and 2023 years of account to the underwriting result for the capacity portfolio in 2023 is as follows:

	2021	2022	2023	2023 Total	2022 Total
Portfolio capacity by underwriting year £m	157.3	245.2	310.8
Gross underwriting result £m	4.6	21.6	5.9	32.1	5.6
Investment income £m	5.2	3.6	1.8	10.6	-3.5
Portfolio result by underwriting year £m	9.8	25.2	7.7	42.7	2.1
Gross result as % of capacity	5.9%	10.4%	2.5%
Retained capacity £m	105.8	184.5	244.5
Helios retained %	67%	75%	79%
Helios share of the portfolio result £m	6.8	19.0	5.8	31.6	0.1

Financial Analysis

The strategy to take advantage of the excellent underwriting conditions, to grow the capacity portfolio over the last three years and to increase retained Helios share of the capacity portfolio has increased capacity portfolio underwriting result to £42.7m (2022: £2.1m).

a) The growth in the capacity portfolio to £245m for 2023 year of account and the improved pricing has contributed an underwriting profit of £25.3m.

b) Helios' increased share of the portfolio for the 2023 underwriting year, increasing to 79%, has made a contribution of £5.8m in 2023 (2022: loss of £7.1m), given the lower incidence of catastrophe losses that were incurred by the supported syndicates.

The development of the earned profits by year of account is shown below.

As a % of capacity	2021	2022	2023
Portfolio profits/(losses) bought forward	0.9%	(4.0%)	-
Portfolio profits earned in the year	5.9%	10.4%	2.7%
Final result/cumulative profits earned to date	6.8%	6.5%	2.7%
Final result/mid-point estimates as at 31 December	6.8%	8.1%	12.0%

During 2023, the 2021 underwriting year result improved from a mid-point result as at 31 December 2022 of 2.4% to a final result of 6.8%, an improvement of 4.4%. There remains uncertainty over the reserves required for the aviation losses incurred in Ukraine. Syndicate 609 - Atrium - has kept the 2021 year of account open, pending the ongoing discussions regarding the potential liability for the aviation losses.

The 2022 year of account was impacted by Hurricane Ian - an insured industry loss of USD55bn which resulted in a loss to the portfolio of 6.1%. Having booked this loss, the mid-point estimate for the 2022 underwriting year at 31 December 2023 is a profit of 8.1% which is expected to improve in 2024, with the remaining profits from this year of account to be earned in 2024. The mid-point estimate for 2023 has initially been reported at 12.0%, an underwriting year that was not materially impacted by catastrophe events. This absence of large losses allowed profits to be recognised at the 12-month stage and the initial mid-point result for 2023 is very promising.

We expect the GAAP earnings in 2024 from the 2023 and 2022 underwriting years to make a significant contribution to Helios' earnings, both from the profitability in the underlying portfolios and with further positive investment returns continuing to be recognised.

Insurance price index (base year 2017 = 100)

2017 100

2018 103

2019 109

2020 121

2021 134

2022 144

2023 151

The Lloyd's market has been in remediation and market-wide pricing correction since 2018 and we have seen seven consecutive years of rate hardening. The 2023 Lloyd's result was the best in recent history, achieving a combined ratio of 84%, evidencing the current rate levels are adequate and resilient to loss activities.

Net combined ratio (%)

Helios Lloyd's

2023* 86

2023* 84

2022 93

2022 92

2021 94

2020 103

2020 110

The below chart shows the return on capital for the Helios capacity portfolio against the returns that could be achieved by the aggregate for capital provided to Lloyd's to support underwriting. Helios portfolio's return on capital outperforms that of Lloyd's by an average of 9.0% over the last four years.

Source: Corporation of Lloyd's

Return on Capital Helios vs Lloyd's Market Performance (%)

Helios Lloyd's of London Helios relative performance

Return on capital has been calculated as:

Helios - The YOA return* on the opening capacity for that YOA as a percentage of the previous year's calendar year* closing Funds at Lloyd's (including reinsurance and solvency adjustments).

Lloyd's - The YOA return* as a percentage of FAL, calculated as the calendar year* closing members, Funds at Lloyd's*.

* Calendar year has been used as a proxy for the YOA capital support.

* YOA return includes prior year movements.

Other income

Helios generates additional income at Group level from the following:

	2023 £'000	2022 £'000
Fees from reinsurers	1,408	562
Corporate reinsurance policies	-	33
Amortisation of goodwill	619	1,216
Investment income	2,103	647
Total other income	4,130	2,458

The investment returns on the assets managed by the supported syndicates are included in the overall portfolio underwriting result.

Financial investments	£'000	Investment return £'000	Yield
Syndicate investment assets	217,444	10,373	4.7%
Group investment assets	70,754	2,103	3.0%
	288,198	12,476	4.3%

Helios' share of the syndicate investments have generated an investment return of 4.7% (2022: loss of 2.2%) and the yields on our investment funds have also improved. These investment funds are now fully invested in a short duration bond portfolio. The share of the syndicate investments have increased by 42% in the year and this is expected to continue to increase, reflecting the growth of the capacity portfolio.

Fees from the quota share reinsurers reflect the fee payable on the Funds at Lloyd's provided and profit commission relating to profits earned on the 2021, 2022 and 2023 years of account has been accrued.

Total costs

The total costs comprise the cost of the stop loss protection bought to mitigate the downside from large underwriting losses, the cost of providing recourse and non-recourse debt to assist in the financing of the capital requirements of the retained capacity and the operating expenses.

	2023 £'000	2022 £'000
Pre-acquisition	494	46
Portfolio stop loss	2,561	1,002
Portfolio funds at Lloyd's Financing	3,112	1,446
Operating costs	6,818	4,033
Total costs	12,985	6,527

The stop loss costs incurred in 2022 have been partially deferred to reflect the exposure of the portfolio that extends over two years. The increased the charge in 2023 reflects the continuation of the spreading of the costs over two years and as the retained capacity increased in 2023. The stop loss provides short-term financing to fund a loss in excess of 7.5% of capacity.

The financing of the retained capacity using excess of loss and bank facilities is also spread over two years. £41m of additional underwriting capital was sourced in 2023 through a reinsurance contract and a £15m bank facility at a cost of £2.8m.

The operating costs have increased as the portfolio management skills have been expanded following the appointment of Martin Reith. In addition, the 2023 costs include a bonus accrual of £1.25m and a provision for FX losses of £0.9m.

Net tangible asset value per share

The growth in the net asset value per share remains a key management metric for determining growth in value to shareholders.

	2023 £'000	2022 £'000
Net tangible assets	57,665	55,743
Fair value and capacity ("WAV")	82,436	59,967
	140,101	115,710
Shares in issue (Note 21)	74,186	76,218
Net tangible asset value per share (£)	1.89	1.51

The capital employed per share, the assets used to generate earnings which exclude the deferred tax liability on capacity value, is as follows:

	2023 £'000	2022 £'000
Net assets	140,101	115,710
Deferred tax provision on capacity value	20,136	14,139
Capital employed	160,237	129,849
Shares in issue (Note 21)	74,186	76,218
Capital employed per share (£)	2	2

The deferred tax provision on capacity value could potentially be incurred should the entire portfolio be sold. The capital employed by share is 32p (2022: 18p), higher than the net tangible asset value per share.

The value of capacity is subject to fluctuation and reflects the activity in the capacity auctions held in the autumn of each year.

Return of capital to shareholders

The Company returns capital to shareholders by way of dividends and share buy-backs.

	2023		2024		Total
	£m	Pence per share	£m	Pence per share	£m	Pence per share
Share buyback - Actual	3.2	4	0.8	1	4.0	5
- Proposed			3.7	5	3.7	5
Dividend - Actual	2.3	3			2.3	3
- Proposed			4.5	6	4.5	6
Total	5.5	7	9.0	12	14.5	19

The Company returns capital to shareholders by way of dividends and share buy-backs. In 2023 a total of £5.5m was returned to shareholders comprising a base dividend of 3p per share and the buying back of shares of £2.3m in 2023 at an average price of £1.42p per share thereby enhancing shareholder value.

In 2024 it is proposed to increase the capital returned to shareholders to £9.0m. A base dividend of 6p per share (£4.5m) is proposed together with a further buy back of shares of up to £3.7m by 31 December 2024.

The aggregate capital returned to shareholder in 2023 and 2024 is expected to be £14.5m - 19p per share.

Capacity value

The value of the portfolio of the syndicate capacity remains the major asset of Helios and an important factor in delivering overall returns to shareholders. The growth in the net asset value ("NAV"), being the value of the net tangible assets of the Company, together with the current value of the portfolio capacity, is a key management metric in determining growth in value to shareholders.

	Freehold capacity £m	Value of capacity £m	Value per £ of capacity
Capacity value at 31 Dec 2022	147.3	60.0	41p
Capacity acquired with LLVs in 2023	7.4	3.5
Value of pre-emption capacity	14.7	7.0
Acquisition of capacity in the capacity auction	6.5	0.4
Increase in portfolio value	-	11.5
Capacity value as at 31 Dec 2023	175.9	82.4	47p

The average price per £ of freehold capacity has increased by 15% to 47p per £ of capacity, reflecting the demand from third party capital for access to the syndicates offering freehold capacity. In addition, the pre-emptions offered increased the value of the portfolio by £7m.

Impact on net asset value	£m
Value of pre-emption capacity	7.0
Increase in portfolio value	11.5
	18.5
Deferred tax provision - 25%	(4.6)
Net increase in tangible net assets	13.9
Number of shares in issue	74.2
Increase in net asset value per share	18.74

The Board recognises that the average prices derived from the annual capacity auctions managed by the corporation of Lloyd's could be subject to material change if the level of demand for syndicate capacity reduces or if the supply of capacity for sale should increase.

A sensitivity analysis of the potential change to the NAV per share from changes to the value of the capacity portfolio is set out below:

	Capacity value £m	Revised NTAV per share
Current value - £m	82.4	1.89
Decrease of 10%	74.2	1.81
Increase of 10%	90.6	1.97

Each 10% reduction in the capacity values at the 2024 auctions will reduce the NAV by approximately 8p per share (2022: 6p per share). The increase in capital base has reduced the impact on NAV per share from changes in capacity value. Any reduction in the value will be mitigated by any pre-emption capacity on syndicates that have a value at auction.

Acquisition strategy

Helios acquired four LLVs in 2023 (2022: three), maintaining an interest in the market for the sale of LLVs in 2023. Given that the improvement in market conditions is now being reflected in the syndicate underwriting results - the interest in the small numbers of LLVs for sale has increased. We will continue to communicate with the owners of LLVs, which has the advantage of:

• raising the profile of Helios;

• allowing owners of LLVs who were potentially considering ceasing underwriting at Lloyd's to have the opportunity to realise the value of their investment quickly;

• allowing vendors a tax-efficient exit if they wish to cease underwriting.

Risk Management

During 2023, a further four LLVs were acquired.

	Summary of acquisitions				Goodwill
	Total consideration £m	Capacity £m	Humphrey value £m	Discount to Humphrey	Negative £'000	Positive £'000
2023	7.1	8.2	8.0	12%	364
2022	5.7	5.7	6.3	10%		374
2021	27.3	34.8	28.9	6%	1,219	319

The four (2022: three) acquisitions in 2023 were purchased for a total consideration of £7.1m (2022: £5.7m), of which £3.2m (2022: £2.6m) was attributed to the value of capacity acquired. Although the LLVs acquired in 2023 were at discount to Humphrey's, subsequently the availability of LLVs at reasonable value has diminished. As the prospect for profitable underwriting has increased, there is greater interest in the LLVs that are available for sale.

The goodwill that is recognised on an acquisition is now amortised in the Financial Statements over three years and in 2023 £619,000 of negative goodwill has been amortised in 2023.

Third party capital

Underwriting capital provided by third parties will form an increasing part of the capital stack of the Helios Capacity Portfolio. Helios has used quota share reinsurance for a number of years to provide access to the Lloyd's underwriting exposures for reinsurers and for the 2024 year of account third party members provided a new source of capital to support the capacity portfolio.

		2023	2024
Current total capacity - £m	QS reinsurers	66.3	63.5
	Third party capital	-	51.7
Total third party capital		66.3	115.2
Helios Capacity Fund - total capacity		310.8	507.1
Helios' share of capacity fund		79%	77%

Third party capital has successfully reduced the exposure of Helios shareholders in recent years and assists in the financing of the underwriting capital. Helios has almost doubled the third party capacity support for the capacity portfolio in 2024 to £115m. It is expected that the support from third party capital will further increase for the 2025 year of account.

For the 2024 year of account, a new structure of participation was offered to existing private capital participants. In conjunction with Argenta Private Capital Limited, its clients were offered the opportunity to participate on the Helios Capacity Portfolio MAPA, including participations on freehold syndicates without having to fund the upfront cost of the freehold capacity rights. Helios is renting the freehold capacity rights to these capital providers with the intention of improving the return on capital for these investors.

The concept of offering private capital participations on the Helios Capacity Portfolio was evolved by setting up ten new LLVs to commence trading for the 2024 year of account with an allocation of the Helios Capacity Portfolio that was initially funded by Helios.

These new LLVs were then offered for sale by Argenta Private Capital and all these LLVs have either been sold or are under offer and the Helios initial funding will be refunded. Helios intention is to retain an LLV with capacity of £4.7m so that Helios staff can commit funds at Lloyd's by way of a deferred bonus scheme to participate on the Helios MAPA.

Issue of A-rated - $75m Unsecured Loan Notes

In December 2023, the Company issued $75m of Unsecured Loan Notes with a rating of A- by KBRA. This loan has a fixed coupon on 9.5% and is repayable after seven years in December 2030. The debt was raised to replace an existing £15m bank facility that was used to assist in the financing of funds at Lloyd's, to fund future underwriting capital requirements and provide general liquidity in the business.

The Notes have a covenant whereby if debt exceeds more than 40% gross assets, then a proportion of the free cash flow has to be utilised to pay down the debt so that the gross asset test is no longer exceeded. See Summary Financial Information for further analysis.

Risk management

At Helios, the effective management of risk is central to our business. We are committed to maintaining a robust risk management framework, which includes comprehensive strategies, policies and procedures to manage risk across all levels of our operations.

Our team has regular communication with syndicates to understand how they manage a wide range of risks, including underwriting, operational, market, credit and liquidity risks. We also understand the importance of stress testing and scenario analysis in managing risk. We regularly conduct these exercises to assess the resilience of the Helios Capacity Portfolio under different conditions. The results of these analyses are used to inform our strategic decision making and capital allocation processes.

Designing and implementing an effective risk management framework is a continuous process, and we are committed to its ongoing development to ensure that it remains fit for purpose as our business evolves. We are confident that our approach to risk management positions us well to mitigate potential risks and capitalise on opportunities as they arise.

Strategic risk

We construct the portfolio for each year while considering a number of key strategic risks. First and foremost, we review performance to date and the strategic direction across the portfolio for future underwriting. Against this we assess in light of our own view of risk, market conditions, pricing adequacy, vulnerability to shock and attritional loss while managing the capital to achieve a diversified, volatility managed and optimised portfolio The maintenance and construction of a portfolio of Lloyd's syndicates remains the strategic objective of the Group. Participations can vary as will the mix in order to optimise the portfolio. The 2023 and 2024 portfolios were built against a backdrop of exceptional market conditions.

Liquidity risk

Liquidity risk is the risk that a company may not be able to meet short-term financial demands. Liquidity risk for an insurance capital provider like Helios can arise from numerous factors. Large claim payouts following a significant loss event which requires further funding of funds at Lloyd's to cover expected syndicate losses can strain cash reserves. Helios financial demands might necessitate asset liquidation, potentially leading to losses in unfavourable market conditions. Large losses could cause breaches of loan covenants, triggering further liquidity pressure. An inability to promptly pay out claims could harm reputation and potentially lead to future business losses.

To mitigate liquidity strains, Helios has arranged short-term financing of £35m for 2024 (2023: £24m) as part of the stop loss reinsurance for its 69% (2023 YOA: 80%) share of the portfolio. The facility can be drawn down if the solvency loss for the 2024 year of account exceeds 7.5% of capacity at any quarter end. In addition, Helios has a committed bank facility of £10m to assist in any short-term financing requirements.

To mitigate these risks, Helios maintains a robust liquidity risk management framework, which includes maintaining sufficient cash reserves, diversifying our portfolio, implementing a comprehensive reinsurance programme, regularly stress testing for large loss scenarios and maintaining strong relationships with reinsurers, lenders and investors.

Underwriting risk

Underwriting risk can arise from inaccurate risk assessment by our syndicates leading to insufficient premiums, more frequent or severe claims than expected, inadequate pricing due to outdated models or market pressure and changes in claim trends post-underwriting due to legal, societal or economic shifts. These can cause a mismatch between premiums charged and claims made.

When assessing a syndicate, it is essential for us that they have effective risk management in place to mitigate underwriting risks. This includes setting appropriate underwriting guidelines, using updated and accurate pricing models and diversifying the risks underwritten to avoid concentration in high-risk areas. Furthermore, syndicates will need to prove to us that prudent underwriting practices and rigorous claims management are in place to control underwriting risk. Helios will also need to be satisfied that adequate reinsurance has been arranged by the syndicates.

At Helios, we are proactive in monitoring the rating environment for each class of our business. We understand that in the dynamic market conditions of today, pricing adequacy can vary significantly across different business classes. Therefore, we use advanced analytical tools and techniques to keep a close eye on the pricing environment across all our business classes. If we identify a class with low pricing adequacy, we are quick to respond, reducing our participation in that class to manage risk and protect our portfolio. This approach allows us to ensure that we maintain a healthy balance in our portfolio, optimising our returns while managing risk effectively. Helios continues to ensure that the portfolio is well diversified across classes of businesses and managing agents at Lloyd's.

The biggest single risk faced by insurers arises from the possibility of mispricing insurance on a large scale. The recent correction in terms and conditions and the actions of Lloyd's to force syndicates to remediate underperforming areas of their books demonstrate the mispricing that has prevailed over the past few years. The results of this remediation work by Lloyd's is starting to be reflected in the results announced by the syndicates supported.

These management teams have weathered multiple market cycles and the risk management skills employed should reduce the possibility of substantial under-reserving of previous year underwriting. There is acceptance that catastrophe exposures were generally under-priced and hence the syndicate managers have been reducing their catastrophe exposures. The broad reinsurance market correction is a fundamental shift in risk versus return metrics presenting opportunities to pivot the portfolio in the future.

We assess the downside risk in the event of a major loss through the≈monitoring of the aggregate net losses estimated by managing agents to the catastrophe risk scenarios ("CRS") prescribed by Lloyd's.

The individual syndicate net exposures will depend on the business underwritten during the year and the reinsurance protections purchased at syndicate level.

The aggregate exceedance probability ("AEP") assesses the potential impact on the balance sheet across the portfolio from either single or multiple large losses with a probability of occurring greater than once in a 30-year period.

In addition, Helios purchases stop loss reinsurance with an indemnity of £35m (2022 YOA: £24m) share of the portfolio with an indemnity of 10% of its share of the capacity and a claim can be made if the loss for the year of account at 36 months exceeds 7.5% of capacity.

The impact on the net asset value of Helios from the disclosed large loss scenarios are as follows:

	Expected loss as % of capacity		Impact on net asset value
	2024	2023	2024	2023
AEP 1 in 30 - whole world natural catastrophe	16.2%	14.3%	15.6%	11.4%
AEP 1 in 30 US/GOM windstorm	10.5%	10.2%	15.6%	11.4%
Terrorism	7.6%	8.4%	15.6%	11.4%
Cyber - cloud cascade	8.2%	6.8%	15.6%	11.4%

The assessment of the impact of the specified events is net of all applicable quota share, stop loss reinsurance contracts and corporation tax but before the likely profits to be generated from the balance of the portfolio in any year. Notwithstanding the reduction in the natural catastrophe exposure in the 2023 portfolio, the impact on net assets has increased as the retained capacity has increased. The similarity on the impact on the net assets from a loss arises as the expected loss will result in only a net retention from the stop loss of 7.5% of capacity.

The graph below shows the impact of the largest losses over the past five years on the Helios portfolio. It gives an indication of the size of insurance market-wide insured loss against the Helios portfolio aggregate losses incurred by supported syndicates at the time of the loss (shown as a percentage of capacity). Despite these major losses, Helios' return on capacity remains positive for each year in the given five-year period, ranging from 3% in 2019 to 12% in 2023*, demonstrating the strength and resilience of the portfolio. The coronavirus loss incurred a loss of 7.4% of 2022 capacity, the largest impact recently.

Largest major losses 2019-2023

Industry insured loss ($bn) Loss to Helios as a % of capacity

* 2022 and 2023 positive returns are based on the latest syndicate forecasts.

Capital position

The underwriting capital required by Lloyd's for the Helios portfolio comprises the funds to support the economic capital requirement of the portfolio and the solvency II adjustments are as follows:

Underwriting capital on underwriting year	2024 £m	2023 £m
Third party capital	31.3	27.8
Excess of loss Funds at Lloyd's	25.8	41.2
Helios' own funds	69.9	60.4
Solvency credits	47.0	0.7
Total	173.7	129.1
Capacity as at	507.1	310.8
Economic capital assessment (ECA)	172	127.8
Capital ratio	35%	41%

The capital ratio has benefited from the growth of the portfolio and this reduction in the capital ratio to 35% is expected to reverse over the next few years. The increase in the solvency credits to £47m reflects the recognised but undistributed syndicate profits as at the end of the year that is currently being used as Funds at Lloyd's to support underwriting requirements. If solvency credits are utilised to support current underwriting capital requirements, any solvency deficits arising from losses in the current year would have to be funded by Helios.

Environmental, social and governance ("ESG") responsibility

Strategy

Helios offers investors exposure to a diversified portfolio of syndicates at Lloyd's of London. As a consequence, Helios is inexorably aligned to the approach Lloyd's takes with regard to the society as a whole in addition to those adopted by the various managing agencies.

Helios currently does not underwrite any risk. We participate in risks written by the syndicates operating in the market, providing private capital support. However, we recognise our responsibility to all our stakeholders and the wider communities in which we do business, and we choose to hold ourselves to high standards of humanity, respect, honesty, individuality and empowerment.

The overarching aim is to generate lasting value through the adoption of sustainable approaches that balance environmental stewardship, social responsibility and sound governance, alongside our remit to achieve sound financial performance.

As a key principle, we aim to take a balanced and reasonable approach to assessing ESG risks as the legal and regulatory frameworks evolve globally. Complying with its regulatory obligations in the UK is of utmost importance, while also recognising its fiduciary duty to its investors to provide investment management services within this evolving framework.

To assist us on this roadmap, we are now a signatory to the UN Principles for Responsible Investment and we strive to adopt the six key principles for responsible investment. Furthermore, we have identified the following tenets to help realise our long-term ESG strategy.

Governance practices

The Board is committed to a high standard of corporate governance and is compliant with the principles of the Quoted Companies Alliance's Corporate Governance Code (the "QCA Code"). The Directors have complied with their responsibilities under Section 172 of the Companies Act 2006 which requires them to act in the way they consider, in good faith, would be most likely to promote the success of the Company for the benefit of its members as a whole. Further information is provided on page 21 in this report and accounts. Additionally, for portfolio management we operate a "three lines of defence" risk governance model.

First line of defence:

The first line of defence includes the portfolio management team involved in business as usual ("BAU") monitoring of risks on the portfolio, data analysis and assessment of new opportunities. This is led by our Head of Portfolio Strategy.

Key considerations are given to human rights related breaches, any regulatory fines and compliance to regulatory requirements when selecting syndicates/partners for our portfolio.

Environmental, social and governance ("ESG") responsibility

Second line of defence:

A working group reviews the information received, any early warning indicators and impact on our portfolio. This group is chaired by the Head of Portfolio Strategy and includes our Head of Distribution and other stakeholders in the business. This group provides oversight and challenge to the first line, reviews overall impact on the portfolio and reviews reputational credentials of the new partners.

Third line of defence:

An independent Committee of key Executives chaired by the CEO reviews the recommendations of the working group before a final decision is taken on the opportunities.

Social responsibility initiatives

• Community engagement activities and philanthropic endeavours form a key area of focus for Helios. A new charity policy was developed in 2023 and we have sponsored several projects that ranged from supporting local communities to collaborating projects aimed at addressing societal and local issues.

• Diversity and inclusion initiatives are essential for fostering an environment where everyone feels valued, respected and empowered. This is a key metric for our success. While Helios' workforce is small and growing, we aim to organically promote and provide equitable opportunities for growth and success to not only employees but also external partners, where possible.

Environmental initiatives and risk management

In the current model, Helios supports the Lloyd's market i.e. syndicates via third party capital. We have a share of the entire portfolio of syndicates we participate in and do not have the ability to select specific risks within a portfolio. The portfolio is a mix of syndicates - including both well-established top quartile performers and new entrants.

While we do not directly and exclusively participate in thermal coal-fired plants, thermal coal mines, oil sands or Arctic energy exploration, we may have indirect exposure through participation in syndicates operating in the Lloyd's market.

We expect that every syndicate in the market is aligned with the expectations set by Lloyd's on ESG. We understand this is a transitional process but, where they fail to meet minimum standards, we will review our involvement in those operations.

To summarise, as an organisation that is evolving, we recognise responsibility to our stakeholders and the wider community and are committed to taking a balanced and sustainable approach to developing and implementing our ESG strategy that is aligned with the regulatory expectations in the jurisdictions we operate in.

Catastrophe risk scenarios ("CRS") - net of syndicate reinsurance (%)

AEP 1 in 30 - whole world natural catastrophes

2024 16.2

2023 14.3

AEP 1 in 30 - US/GOM windstorm

2024 10.5

2023 10.2

RDS terrorism - Rockefeller Center

2024 7.8

2023 8.4

Cyber - cloud cascade

2024 8.3

2023 6.8

Summary financial information

The information set out below is a summary of the key items that the Board assesses in estimating the financial position of the Group. Given the Board has no active role in the management of the syndicates within the portfolio, the following approach is taken:

a) It relies on the financial information provided by each syndicate.

b) It calculates the amounts due to/from the quota share reinsurers in respect of their share of the profits/losses as well as fees and commissions due.

c) An adjustment is made to exclude pre-acquisition profits on companies bought in the year.

d) Costs relating to stop loss reinsurance and operating costs are deducted.

	Year to 31 December
	2023 £'000	2022 £'000
Underwriting profit	31,560	116
Other income:
- fees from reinsurers	1,408	562
- corporate reinsurance policies	-	33
- goodwill on bargain purchase	-	-
Amortisation of Goodwill	619	1,216
- investment income	2,103	647
Total other income	4,130	2,458
Costs:
- pre-acquisition	(494)	(46)
- stop loss costs	(4,138)	(1,261)
- operating costs	(8,353)	(5,220)
Total costs	(12,985)	(6,527)
Operating profit before impairments of goodwill and capacity	22,704	(3,953)
Tax	(6,334)	1,852
Revaluation of syndicate capacity	17,987	2,670
Income tax relating to the components of other comprehensive income	(4,497)	(668)
Comprehensive income/loss	29,861	(99)

Year to 31 December 2023

Underwriting year	Helios retained capacity at 31 December 2023 £m	Portfolio mid-point forecasts	Helios profits £'000
2021	102.3	6.8%	6,831
2022	180.9	8.1%	18,949
2023	244.5	12%	5,780
			31,560

Year to 31 December 2022

Underwriting year	Helios retained capacity at 31 December 2022 £m	Portfolio mid-point forecasts	Helios profits £'000
2020	72.0	3.1%	2,647
2021	99.3	2.4%	4,546
2022	177.6	5.8%	(7,077)
			116

Summary balance sheet (excluding assets and liabilities held by syndicates)

See Note 28 for further information

	2023 £'000	2022 £'000
Intangible assets	82,117	59,375
Funds at Lloyd's	70,754	73,771
Other cash	40,913	10,254
Other assets	4,876	6,909
Total assets	198,660	150,309
Deferred tax	22,277	11,228
Borrowings	59,055	15,000
Other liabilities	12,081	3,839
Total liabilities	93,413	30,067
Total syndicate equity	34,854	(5,123)
Total equity	140,101	115,119

Cash flow

	Year to 31 December
Analysis of free working capital	2023 £'000	2022 £'000
Opening Balance	10,254	16,178
Distribution of profits (net of tax retentions & QS Payments )	2,530	2,736
Transfers from Funds at Lloyd's	9,984	4,772
Other income	2,727	280
Sale / Purchase of capacity	(500)	5,051
Operating costs (inc Hampden / Nomina fees)	(7,716)	(4,099)
Reinsurance costs	(3,520)	(3,377)
Tax	(236)	(342)
Return of capital to shareholders	(5,181)	(2,034)
Transfers to Funds at Lloyd's	(4,331)	(31,578)
Free cash Flow	(6,243)	(16,170)
Senior debt principal	59,055	15,000
Repayment of Borrowings	(15,000)	-
Proceeds from issue of shares	-	12,421
Acquisitions	(7,153)	(4,754)
Net cash flow in the year	30,659	(5,924)
Balance carried forward	40,913	10,254

Asset value calculation	2023	2022
Net Assets	140,101	117,178
Add Total Debt	59,055	15,000
Add Deferred Tax on Intangible Asset	20,136	14,139
Asset Value	219,293	146,317
Debt ratio	27%	10%

Summary Financial Information

	Year to 31 December
Net tangible assets	2023 £'000	2022 £'000
Net assets less intangible assets	57,665	55,152
Fair value of capacity ("WAV")	82,436	59,967
	140,100	115,119
Shares in issue - on the market (Note 21)	74,186	76,218
Shares in issue - total of on the market and JSOP shares (Note 21)	75,286	77,318
Net tangible asset value per share £ - on the market	1.89	1.51
Net tangible asset value per share £ - on the market and JSOP shares	1.86	1.49

Combined ratio summary of Helios' portfolio (see Note 6)	2023	2022
Net premiums earned	219,440	156,606
Net insurance claims	(107,909)	(96,796)
Operating expenses included in underwriting result	(79,405)	(54,210)
Insurance result	32,126	5,600
Combined ratio	85.4%	96.4%

Consolidated statement of comprehensive income - Year ended 31 December 2023

	Note	Year ended 31 December 2023 £'000	Year ended 31 December 2022 £'000
Technical account
Gross premium written	6	307,770	244,615
Reinsurance premium ceded	6	(79,531)	(56,977)
Net premium written	6	228,239	187,638
Change in unearned gross premium provision	7	(30,420)	(45,723)
Change in unearned reinsurance premium provision	7	3,161	8,478
Net change in unearned premium and reinsurance provision	7	(27,259)	(37,245)
Net earned premium	5,6	200,980	150,393
Net investment income	8	11,073	(3,442)
Other underwriting income		888	1,127
Revenue		212,941	148,078
Gross claims paid		(92,697)	(66,652)
Reinsurers' share of gross claims paid		21,722	15,832
Claims paid, net of reinsurance		(70,975)	(50,820)
Change in provision for gross claims	7	(33,429)	(63,339)
Reinsurers' share of change in provision for gross claims	7	(2,000)	18,320
Net change in provision for claims	7	(35,429)	(45,019)
Net insurance claims incurred and loss adjustment expenses	6	(106,404)	(95,839)
Expenses incurred in insurance activities		(79,236)	(53,828)
Total technical account	9	27,301	(1,589)
Non-technical account
Net investment income	8	1,986	666
Other income		(63)	(399)
Other operating expenses		(7,138)	(3,847)
Total non-technical account	9	(5,215)	(3,580)
Operating profit before impairments of goodwill and capacity	6	22,086	(5,169)
Amortisation of goodwill		619	1,216
Profit/(loss) before tax		22,705	(3,953)
Income tax (charge)/credit	10	(6,334)	1,852
Profit/(loss) for the year		16,371	(2,101)
Other comprehensive income
Revaluation of syndicate capacity		17,987	2,670
Deferred tax relating to the components of other comprehensive income		(4,497)	(668)
Other comprehensive income for the year, net of tax		13,490	2,002
Total comprehensive income/(loss) for the year		29,861	(99)
Profit/(loss) for the year attributable to owners of the Parent		16,371	(2,101)
Total comprehensive income/(loss) for the year attributable to owners of the Parent		29,861	(99)
Profit/(loss) per share attributable to owners of the Parent
Basic	11	21.56p	(3.08)p
Diluted	11	20.85p	(3.08)p

The profit/(loss) attributable to owners of the Parent, the total comprehensive income/(loss) and the earnings per share set out above are in respect of continuing operations.

The notes are an integral part of these Financial Statements.

Consolidated statement of financial position - At 31 December 2023

Company number: 05892671

	Note	31 December 2023 £'000	31 December 2022 £'000
Assets
Intangible assets:
- Capacity	13	82,436	59,966
- Positive goodwill	13	348	482
- Negative goodwill	13	(667)	(1,073)
Financial assets at fair value through profit or loss	15	288,198	226,013
Reinsurance assets:
- reinsurers' share of claims outstanding	7	83,008	80,726
- reinsurers' share of unearned premium	7	23,962	21,333
Other receivables, including insurance and reinsurance receivables	16	172,932	147,676
Cash and cash equivalents		66,812	25,300
Prepayments and accrued income		7,281	5,076
Deferred acquisition costs	17	32,291	24,991
Total assets		756,601	590,490
Liabilities
Equity
Equity attributable to owners of the Parent:
Share capital	21	7,795	7,774
Share premium	21	98,596	98,268
Revaluation reserve		24,840	11,350
Other reserves - treasury shares (JSOP and LTIP)		190	(110)
Retained earnings		8,680	(2,163)
Total equity		140,101	115,119
Technical provisions
- claims outstanding	7	309,188	272,015
- unearned premium	7	143,610	114,663
Deferred income tax liabilities	18	22,335	11,312
Borrowings	19	59,055	15,000
Other payables, including insurance and reinsurance payables	20	70,594	54,893
Accruals and deferred income		11,718	7,488
Total liabilities		616,500	475,371
Total liabilities and equity		756,601	590,490

The Financial Statements were approved and authorised for issue by the Board of Directors on 29 May 2024, and were signed on its behalf by:

Martin Reith

Chief Executive Officer

29 May 2024

The notes are an integral part of these Financial Statements.

Parent Company statement of financial position - At 31 December 2023

Company number: 05892671

	Note	31 December 2023 £'000	31 December 2022 £'000
Assets
Investments in subsidiaries	14	80,005	65,546
Financial assets at fair value through profit or loss	15	898	731
Other receivables	16	74,120	74,783
Cash and cash equivalents		40,596	9,348
Total assets		195,619	150,408
Liabilities
Borrowings	19	59,055	15,000
Other payables	20	8,847	5,130
Total liabilities		67,902	20,130
Equity
Equity attributable to owners of the Parent:
Share capital	21	7,795	7,774
Share premium	21	98,596	98,268
Other reserves		300	-
		106,691	106,042
Retained earnings:
At 1 January		24,236	27,112
Profit/(loss) for the year		2,318	(842)
Other changes in retained earnings		(5,528)	(2,034)
At 31 December		21,026	24,236
Total equity		127,717	130,278
Total liabilities and equity		195,619	150,408

The Financial Statements were approved and authorised for issue by the Board of Directors on 29 May 2024, and were signed on its behalf by:

Martin Reith

Chief Executive Officer

29 May 2024

The notes are an integral part of these Financial Statements.

Consolidated statement of changes in equity - Year ended 31 December 2023

		Attributable to owners of the Parent
	Note	Share capital £'000	Share premium £'000	Revaluation reserve	Other reserves (JSOP) £'000	Retained earnings £'000	Total equity £'000
At 1 January 2022		6,931	86,330	9,348	(110)	1,972	104,471
Total comprehensive income for the year:
Loss for the year		-	-	-	-	(2,101)	(2,101)
Other comprehensive income, net of tax		-	-	2,002	-	-	2,002
Total comprehensive income for the year		-	-	2,002	-	(2,101)	(99)
Transactions with owners:
Dividends paid	12	-	-	-	-	(2,034)	(2,034)
Company buyback of ordinary shares	21, 23	-	-	-	-	-	-
Share issue, net of transaction cost	21	843	11,938	-	-	-	12,781
Other comprehensive income, net of tax		-	-	-	-	-	-
Total transactions with owners		843	11,938	-	-	(2,034)	10,747
At 31 December 2022		7,774	98,268	11,350	(110)	(2,163)	115,119
At 1 January 2023		7,774	98,268	11,350	(110)	(2,163)	115,119
Total comprehensive income for the year:
Loss for the year		-	-	-	-	16,371	16,371
Other comprehensive income, net of tax		-	-	13,490	-	-	13,490
Total comprehensive income for the year		-	-	13,490	-	16,371	29,861
Transactions with owners:
Dividends paid	12	-	-	-	-	(2,319)	(2,319)
Company buyback of ordinary shares	21, 23	-	-	-	-	(3,209)	(3,209)
Share issue, net of transaction cost	21	21	328	-	300	-	649
Other comprehensive income, net of tax		-	-	-	-	-	-
Total transactions with owners		21	328	-	300	(5,528)	(4,879)
At 31 December 2023		7,795	98,596	24,840	190	8,680	140,101

The notes are an integral part of these Financial Statements.

Parent Company statement of changes in equity - Year ended 31 December 2023

	Note	Share capital £'000	Share premium £'000	Other reserves (JSOP) £'000	Retained earnings £'000	Total equity £'000
At 1 January 2022		6,931	86,330	-	27,112	120,373
Total comprehensive income for the year:
Profit/(loss) for the year		-	-	-	(842)	(842)
Other comprehensive income, net of tax		-	-	-	-	-
Total comprehensive income/(loss) for the year		-	-	-	(842)	(842)
Transactions with owners:
Dividends paid	12	-	-	-	(2,034)	(2,034)
Company buyback of ordinary shares	21, 23	-	-	-	-	-
Share issue, net of transaction costs		843	11,938	-	-	12,781
Total transactions with owners		843	11,938	-	(2,034)	10,747
At 31 December 2022		7,774	98,268	-	24,236	130,278
At 1 January 2023		7,774	98,268	-	24,236	130,278
Total comprehensive income for the year:
Profit for the year		-	-	-	2,318	2,318
Other comprehensive income, net of tax		-	-	-	-	-
Total comprehensive income for the year		-	-	-	2,318	2,318
Transactions with owners:		-	-	-	(3,209)	(3,209)
Dividends paid	12	-	-	-	(2,319)	(2,319)
Company buyback of ordinary shares	21, 23	-	-	-	-	-
Share issue, net of transaction costs		21	328	300	-	649
Total transactions with owners		21	328	300	5,528	(4,879)
At 31 December 2023		7,795	98,596	300	21,026	127,717

The notes are an integral part of these Financial Statements.

Consolidated statement of cash flows - Year ended 31 December 2023

	Note	Year ended 31 December 2023 £'000	Year ended 31 December 2022 £'000
Cash flows from operating activities
Profit/(loss) before tax		22,705	(3,953)
Adjustments for:
- interest received	8	(2,036)	(520)
- Interest paid on borrowings		1,622	797
- investment income	8	(6,026)	(2,350)
- amortisation of goodwill	22	(619)	(1,216)
- profit on sale of intangible assets		30	(262)
Changes in working capital:
- change in fair value of financial assets held at fair value through profit or loss	8	(5,570)	4,490
- increase in financial assets at fair value through profit or loss		(54,799)	(66,153)
- decrease in other receivables		(18,862)	(65,566)
- increase in other payables		16,730	15,600
- net increase in technical provisions		50,330	92,262
Cash generated by/(used in) in operations		3,505	(26,871)
Income tax paid		(602)	(166)
Net cash generated/(used in) operating activities		2,903	(27,037)
Cash flows from investing activities
Interest received	8	2,036	520
Investment income	8	6,026	2,350
Purchase of intangible assets	13	(500)	(696)
Proceeds from disposal of intangible assets		34	5,373
Acquisition of subsidiaries, net of cash acquired		(6,540)	(4,784)
Net cash from investing activities		1,056	2,763
Cash flows from financing activities
Net proceeds from issue of ordinary share capital		649	12,781
Buyback of ordinary share capital		(3,209)	-
Proceeds from borrowings	19	59,055	15,000
Repayment of borrowings	19	(15,000)	-
Interest paid on borrowings		(1,622)	(797
Dividends paid to owners of the Parent	12	(2,319)	(2,034)
Net cash from financing activities		37,554	24,950
Net increase in cash and cash equivalents		41,513	676
Cash and cash equivalents at beginning of year		25,299	24,624
Cash and cash equivalents at end of year		66,812	25,300

Analysis of changes in net debt

	At 1 January 2023	Cash flows	Acquired with Subsidiaries	At 31 December 2023
	£000	£000	£000	£000
Cash at bank and in hand	25,299	40,808	705	66,812
Cash and cash equivalents	25,299	40,808	705	66,812
Revolving Loan Facility	(15,000)	15,000	-	-
Unsecured debt	-	(59,055)	-	(59,055)
Total	10,299	(3,247)	705	7,757

Cash held within the syndicates' accounts is £25,899 (2022: £15,046,000) of the total cash and cash equivalents held at the year end of £61,078,000 (2022: £25,300,000). The cash held within the syndicates' accounts is not available to the Group to meet its day-to-day working capital requirements.

Cash and cash equivalents comprise cash at bank and in hand.

The notes are an integral part of these Financial Statements.

Parent Company statement of cash flows - Year ended 31 December 2023

	Note	Year ended 31 December 2023 £'000	Year ended 31 December 2022 £'000
Cash flows from operating activities
Profit/(loss) before tax		2,318	(842)
Adjustments for:
- investment income		65	108
- dividends received		-	-
- impairment of investment in subsidiaries	14	(8,063)	7,218
Changes in working capital:
- change in fair value of financial assets held at fair value through profit or loss		-	-
- increase in financial assets at fair value through profit or loss		(167)	(446)
- (decrease) in other receivables		(5,184)	(241)
- increase in other payables		3,741	918
Net cash (used in)/from operating activities		(7,290)	6,715
Cash flows from investing activities
Investment income		(65)	(108)
Dividends received		-	-
Acquisition of subsidiaries	14, 22	(7,268)	(5,352)
Amounts owed by subsidiaries	25	6,695	(31,748)
Net cash used in investing activities		(638)	(37,208)
Cash flows from financing activities
Net proceeds from the issue of ordinary share capital		649	12,781
Payment for Company buyback of shares	24	(3,209)	-
Proceeds from borrowings	19	59,055	15,000
Repayment of borrowings	19	(15,000)	-
Dividends paid to owners of the Parent	12	(2,319)	(2,034)
Net cash from financing activities		39,176	25,747
Net increase/(decrease) in cash and cash equivalents		31,248	(4,746)
Cash and cash equivalents at beginning of year		9,348	14,094
Cash and cash equivalents at end of year		40,596	9,348

Analysis of changes in net debt

	At 1 January 2023	Cash flows	Acquired with Subsidiaries	At 31 December 2023
	£000	£000	£000	£000
Cash at bank and in hand	9,347	32,171	(923)	40,596
Cash and cash equivalents	9,347	32,171	(923)	40,596
Revolving Loan Facility	(15,000)	15,000	-	-
Unsecured debt	-	(59,055)	-	(59,055)
Total	(5,653)	(11,884)	(923)	(18,459)

Cash and cash equivalents comprise cash at bank and in hand.

The notes are an integral part of these Financial Statements.

Notes to the Financial Statements - Year ended 31 December 2023

1. General information

The Company is a public limited company listed on AIM. The Company was incorporated in England and is domiciled in the UK and its registered office is 1st Floor, 33 Cornhill, London, United Kingdom EC3V 3ND. These Financial Statements comprise the Company and its subsidiaries (together referred to as the "Group"). The Group participates in insurance business as an underwriting member at Lloyd's through its subsidiary undertakings.

2. Significant accounting policies

The Financial Statements have been prepared under the historical cost convention as modified by the revaluation of the financial assets at fair value through the statement of comprehensive income.

The 31 December 2022 Financial Statements were prepared in accordance International Financial Reporting Standards (IFRSs). The 31 December 2023 Financial Statements have been prepared in accordance with United Kingdom Accounting Standards (UK GAAP), including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and FRS 103 "Insurance Contracts".

The reason for this change in reporting framework is that it is not possible for the Directors to obtain financial information in respect of the underlying syndicate participations that would be required to comply with IFRS 17 "Insurance Contracts" which is effective under IFRS for accounting periods beginning on or after 1 January 2023 (see note 29).

The same accounting policies, presentation and methods of computation are followed in these Condensed Consolidated Interim Financial Statements as were applied in the preparation of the Group Financial Statements for the year ended 31 December 2022 except the following as a result of the conversion from IFRS to UK GAAP:

• positive goodwill which is taken to the consolidated statement of financial position (CSOFP) is now amortised over the its estimated useful life of three years (see Note 29); and

• goodwill on bargain purchases which was taken straight to the consolidated statement of comprehensive income (CSOCI) under IFRS is now capitalised and taken the CSOFP and amortised over its estimated useful life of three years (see Note 29).

Basis of preparation

These Financial Statements have been prepared in accordance with United Kingdom Accounting Standards ("UK GAAP"), including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and FRS 103 "Insurance Contracts" and the Companies Act 2006 and Schedule 3 of the Large and Medium sized Companies and Groups (Accounts and Reports) Regulations, relating to insurance.

The 31 December 2022 and these Financial Statements were prepared under International Financial Reporting Standards (IFRSs) and the prior period figures have been amended to reflect the changes in the reporting framework (see note 29).

No statement of comprehensive income is presented for Helios Underwriting plc, as a Parent Company, as permitted by Section 408 of the Companies Act 2006.

The Financial Statements have been prepared under the historical cost convention as modified by the revaluation of financial assets at fair value through profit or loss.

Use of judgements and estimates

The preparation of Financial Statements in conformity with UK GAAP requires the use of judgements, estimates and assumptions in the process of applying the Group's accounting policies that affect the reported amounts of assets and liabilities at the date of the Financial Statements and the reported amounts of revenues and expenses during the reporting year. Although these estimates are based on management's best knowledge of the amounts, events or actions, actual results may ultimately differ from these estimates. Further information is disclosed in Note 3.

The Group participates in insurance business through its Lloyd's member subsidiaries. Accounting information in respect of syndicate participations is provided by the syndicate managing agents and is reported upon by the syndicate auditors.

Going concern

The Group and the Company have net assets at the end of the reporting period of £140,101,000 and £127,717,000 respectively.

The Company's subsidiaries participate as underwriting members at Lloyd's on the 2021, 2022 and 2023 years of account, as well as any prior run-off years, and they have continued this participation since the year end on the 2024 year of account. This underwriting is supported by funds at Lloyd's totalling £173,700,000 (2022: £99,840,000), letters of credit provided through the Group's reinsurance agreements totalling £31,576,000 (2022: £27,818,000) and solvency credits issued by Lloyd's totalling £46,988,000 (2022: £1,331,000).

The Directors have a reasonable expectation that the Group and the Company have adequate resources to meet their underwriting and other operational obligations for the foreseeable future. Accordingly, they continue to adopt the going concern basis of accounting in preparing the annual Financial Statements.

Principles of consolidation, business combinations and goodwill

(a) Consolidation and investments in subsidiaries

The Group Financial Statements incorporate the Financial Statements of Helios Underwriting plc, the Parent Company, and its directly and indirectly held subsidiaries.

The Financial Statements for all of the above subsidiaries are prepared for the year ended 31 December 2023 under UK GAAP.

No income statement is presented for Helios Underwriting plc as permitted by Section 408 of the Companies Act 2006. The profit after tax for the year of the Parent Company was £2,318,000 (2022: loss of £842,000).

Subsidiaries are entities over which the Group has the power to govern the financial and operating policies generally accompanying a shareholding or partnership participation of more than one half of the voting rights. The existence and effect of potential voting rights that are currently exercisable or convertible are considered when assessing whether the Group controls another entity.

Subsidiaries are fully consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date that control ceases.

Intra-group transactions, balances and unrealised gains on intra-group transactions are eliminated.

In the Parent Company's Financial Statements, investments in subsidiaries are stated at cost and are reviewed for impairment annually or when events or changes in circumstances indicate the carrying value to be impaired.

(b) Business combinations and goodwill

The Group uses the acquisition method of accounting to account for the acquisition of subsidiaries. The cost of an acquisition is measured as the fair value of the assets given, equity instruments issued and liabilities incurred or assumed at the date of exchange. Acquisition costs are expensed as incurred.

The excess of the cost of acquisition over the fair value of the Group's share of the identifiable net assets acquired is capitalised and recorded as goodwill. Following initial recognition, goodwill is measured at cost less accumulated impairment losses. Goodwill is amortised on a straight line basis over three years. Insurance liabilities are not discounted on acquisition when calculating their fair value, as these liabilities will likely all crystallise within three years due to the accounting framework Lloyd's syndicates operate under. Accordingly, any discount applied to insurance liabilities will not be material.

Segmental reporting

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker. The chief operating decision maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as Martin Reith.

Foreign currency translation

Items included in the Financial Statements of each of the Group's entities are measured using the currency of the primary economic environment in which the entity operates (the "functional currency"). The Financial Statements are presented in thousands of pounds sterling, which is the Group's functional and presentational currency. All amounts have been rounded to the nearest thousand, unless otherwise indicated.

Foreign currency transactions and non-monetary assets and liabilities, including deferred acquisition costs and unearned premiums, are translated into the functional currency using annual average rates of exchange prevailing at the time of the transaction as a proxy for the transactional rates. The translation difference arising on non-monetary asset items is recognised in the consolidated statement of comprehensive income.

Certain supported syndicates have non-sterling functional currencies and any exchange movement that they would have been reflected in other comprehensive income. As a result, this has been included within profit before tax at consolidation level, to be consistent with the Group's policy of using sterling as the functional currency.

Monetary items are translated at period-end rates; any exchange differences arising from the change in rates of exchange are recognised in the consolidated income statement of the year.

Underwriting

Premiums

Gross premium written comprises the total premiums receivable in respect of business incepted during the year, together with any differences between booked premiums for prior years and those previously accrued, and includes estimates of premiums due but not yet receivable or notified to the syndicates on which the Group participates, less an allowance for cancellations. All premiums are shown gross of commission payable to intermediaries and exclude taxes and duties levied on them.

Unearned premiums

Gross premium written is earned according to the risk profile of the policy. Unearned premiums represent the proportion of gross premium written in the year that relates to unexpired terms of policies in force at the end of the reporting period calculated on a time apportionment basis having regard, where appropriate, to the incidence of risk. The specific basis adopted by each syndicate is determined by the relevant managing agent.

Deferred acquisition costs

Acquisition costs, which represent commission and other related expenses, are deferred over the period in which the related premiums are earned.

Reinsurance premiums

Reinsurance premium costs are allocated by the managing agent of each syndicate to reflect the protection arranged in respect of the business written and earned.

Reinsurance premium costs in respect of reinsurance purchased directly by the Group are charged or credited based on the annual accounting result for each year of account protected by the reinsurance.

Claims incurred and reinsurers' share

Claims incurred comprise claims and settlement expenses (both internal and external) occurring in the year and changes in the provisions for outstanding claims, including provisions for claims incurred but not reported ("IBNR") and settlement expenses, together with any other adjustments to claims from previous years. Where applicable, deductions are made for salvage and other recoveries.

The provision for claims outstanding comprises amounts set aside for claims notified and IBNR. The amount included in respect of IBNR is based on statistical techniques of estimation applied by each syndicate's in-house reserving team and reviewed, in certain cases, by external consulting actuaries. These techniques generally involve projecting from past experience the development of claims over time to form a view of the likely ultimate claims to be experienced for more recent underwriting, having regard to variations in the business accepted and the underlying terms and conditions. The provision for claims also includes amounts in respect of internal and external claims handling costs. For the most recent years, where a high degree of volatility arises from projections, estimates may be based in part on output from the rating and other models of the business accepted, and assessments of underwriting conditions.

The reinsurers' share of provisions for claims is based on calculated amounts of outstanding claims and projections for IBNR, net of estimated irrecoverable amounts, having regard to each syndicate's reinsurance programme in place for the class of business, the claims experience for the year and the current security rating of the reinsurance companies involved. Each syndicate uses a number of statistical techniques to assist in making these estimates.

Accordingly, the two most critical assumptions made by each syndicate's managing agent as regards claims provisions are that the past is a reasonable predictor of the likely level of claims development and that the rating and other models used, including pricing models for recent business, are reasonable indicators of the likely level of ultimate claims to be incurred.

The level of uncertainty with regard to the estimations within these provisions generally decreases with time since the underlying contracts were exposed to new risks. In addition, the nature of short-tail risks, such as property where claims are typically notified and settled within a short period of time, will normally have less uncertainty after a few years than long-tail risks, such as some liability businesses where it may be several years before claims are fully advised and settled. In addition to these factors, if there are disputes regarding coverage under policies or changes in the relevant law regarding a claim, this may increase the uncertainty in the estimation of the outcomes.

The assessment of these provisions is usually the most subjective aspect of an insurer's accounts and may result in greater uncertainty within an insurer's accounts than within those of many other businesses. The provisions for gross claims and related reinsurance recoveries have been assessed on the basis of the information currently available to the Directors of each syndicate's managing agent. However, ultimate liability will vary as a result of subsequent information and events and this may result in significant adjustments to the amounts provided. Adjustments to the amounts of claims provisions established in prior years are reflected in the Financial Statements for the period in which the adjustments are made. The provisions are not discounted for the investment earnings that may be expected to arise in the future on the funds retained to meet the future liabilities. The methods used, and the estimates made, are reviewed regularly.

Quota share reinsurance

Under the Group's quota share reinsurance agreements, 47% of the 2021 underwriting year, an average of 26% of the 2022 underwriting year and an average of 23% of the 2023 underwriting year of account insurance exposure is ceded to the reinsurers. Amounts payable to the reinsurers are included within "reinsurance premium ceded" in the consolidated statement of comprehensive income of the year and amounts receivable from the reinsurers are included within "reinsurers' share of gross claims paid" in the consolidated statement of comprehensive income of the year.

Unexpired risks provision

Provision for unexpired risks is made where the costs of outstanding claims, related expenses and deferred acquisition costs are expected to exceed the unearned premium provision carried forward at the end of the reporting period. The provision for unexpired risks is calculated separately by reference to classes of business that are managed together, after taking into account relevant investment return. The provision is made on a syndicate-by-syndicate basis by the relevant managing agent.

Closed years of account

At the end of the third year, the underwriting account is normally closed by reinsurance into the following year of account. The amount of the reinsurance to close premium payable is determined by the managing agent, generally by estimating the cost of claims notified but not settled at 31 December, together with the estimated cost of claims incurred but not reported ("IBNR") at that date and an estimate of future claims handling costs. Any subsequent variation in the ultimate liabilities of the closed year of account is borne by the underwriting year into which it is reinsured.

The payment of a reinsurance to close premium does not eliminate the liability of the closed year for outstanding claims. If the reinsuring syndicate was unable to meet any obligations, and the other elements of Lloyd's chain of security were to fail, then the closed underwriting account would have to settle any outstanding claims.

The Directors consider that the likelihood of such a failure of the reinsurance to close is extremely remote and consequently the reinsurance to close has been deemed to settle the liabilities outstanding at the closure of an underwriting account. The Group will include its share of the reinsurance to close premiums payable as technical provisions at the end of the current period and no further provision is made for any potential variation in the ultimate liability of that year of account.

Run-off years of account

Where an underwriting year of account is not closed at the end of the third year (a "run-off" year of account) a provision is made for the estimated cost of all known and unknown outstanding liabilities of that year. The provision is determined initially by the managing agent on a similar basis to the reinsurance to close. However, any subsequent variation in the ultimate liabilities for that year remains with the corporate member participating therein. As a result, any run-off year will continue to report movements in its results after the third year until such time as it secures a reinsurance to close.

Net operating expenses (including acquisition costs)

Expenses incurred in insurance activities include acquisition costs, profit and loss on exchange and other amounts incurred by the syndicates on which the Group participates.

Acquisition costs, comprising commission and other costs related to the acquisition of new insurance contracts, are deferred to the extent that they are attributable to premiums unearned at the end of the reporting period.

Investment income

Interest receivable from cash and short-term deposits and interest payable are accrued to the end of the period.

Dividend income from financial assets at fair value through profit or loss is recognised in the income statement when the Group's right to receive payments is established.

Syndicate investments and cash are held on a pooled basis, the return from which is allocated by the relevant managing agent to years of account proportionate to the funds contributed by the year of account.

Other operating expenses

All expenses are accounted for on an accruals basis.

Intangible assets: syndicate capacity

With effect from 31 December 2020, the Group changed this policy so that syndicate capacity is revalued on a regular basis to its fair value which the Directors believe to be the average weighted value achieved in the Lloyd's auction process. The increase in value of syndicate capacity between its fair value and its cost less impairment is taken to the revaluation reserve through the statement of other comprehensive income net of any tax effect.

Financial assets

(a) Classification

The Group classifies its financial assets in the following categories: at fair value through profit or loss, and loans and receivables. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition. The Group does not make use of the held-to-maturity and available-for-sale classifications.

(i) Financial assets at fair value through profit or loss

All financial assets at fair value through profit or loss are categorised as designated at fair value through profit or loss upon initial recognition because they are managed and their performance is evaluated on a fair value basis in accordance with the Group's documented investment strategy. Information about these financial assets is provided internally on a fair value basis to the Group's key management.

The Group's investment strategy is to invest and evaluate their performance with reference to their fair values. Assets in this category are classified as current assets if expected to be settled within 12 months; otherwise, they are classified as non-current.

(ii) Loans and receivables

Loans and receivables are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They are classified as current assets, except for maturities greater than 12 months after the reporting period. The latter ones are classified as non-current assets.

The Group's loans and receivables comprise "other receivables, including insurance and reinsurance receivables" and "cash and cash equivalents".

The Parent Company's loans and receivables comprise "other receivables" and "cash and cash equivalents".

(b) Recognition, derecognition and measurement

Regular purchases and sales of financial assets are recognised on the trade date, being the date on which the Group commits to the purchase or sale of the asset. Financial assets are derecognised when the right to receive cash flows from the financial assets has expired or is transferred and the Group has transferred substantially all its risks and rewards of ownership.

Financial assets at fair value through profit or loss are initially recognised at fair value and transaction costs incurred expensed in the income statement.

Loans and receivables are initially recognised at fair value plus transaction costs and are subsequently carried at amortised cost less any impairment losses.

Fair value estimation

The fair value of financial assets at fair value through profit or loss which are traded in active markets is based on quoted market prices at the end of the reporting period. A market is regarded as active if quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing service or regulatory agency and those prices represent actual and regular occurring market transactions on an arm's length basis. The quoted market price used for financial assets at fair value through profit or loss held by the Group is the current bid price.

The fair value of financial assets at fair value through profit or loss that are not traded in an active market is determined by using valuation techniques. These valuation techniques maximise the use of observable market data where it is available and rely as little as possible on entity-specific estimates.

Unrealised gains and losses arising from changes in the fair value of the financial assets at fair value through profit or loss are presented in the income statement within "net investment income".

The fair values of short-term deposits are assumed to approximate to their book values. The fair values of the Group's debt securities have been based on quoted market prices for these instruments.

The Group assesses at the end of each reporting period whether there is objective evidence that a financial asset or group of financial assets is impaired. A financial asset or a group of financial assets is impaired and impairment losses are incurred only if there is objective evidence of impairment as a result of one or more events that occurred after the initial recognition of the asset (a "loss event") and that loss event (or events) has an impact on the estimated future cash flows of the financial asset or group of financial assets that can be reliably estimated.

Asset carried at amortised cost

For loans and receivables, the amount of the loss is measured as the difference between the asset's carrying amount and the present value of the estimated future cash flows (excluding future credit losses that have not been incurred) discounted at the financial asset's original effective interest rate. The carrying amount of the asset is reduced and the amount of the loss is recognised in profit or loss. If a loan has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract. As a practical expedient, the Group may measure impairment on the basis of an instrument's fair value using an observable market price.

If, in a subsequent period, the amount of the impairment loss decreases and the decrease can be related objectively to an event occurring after the impairment was recognised (such as an improvement in the debtor's credit rating), the reversal of the previously recognised impairment loss is recognised in profit or loss.

Cash and cash equivalents

For the purposes of the statements of cash flows, cash and cash equivalents comprise cash and short-term deposits at bank.

Borrowings

Borrowings are recognised initially at fair value, net of transaction costs incurred. Borrowings are subsequently carried at amortised cost; any difference between the proceeds (net of transaction costs) and the redemption value is recognised in the income statement over the period of the borrowings, using the effective interest method.

Fees paid on the establishment of loan facilities are recognised as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down. To the extent that there is no evidence that it is probable that some or all of the facility will be drawn down, the fee is capitalised as a prepayment for liquidity services, and amortised over the period of the facility to which it relates.

Borrowings are classified as current liabilities unless the Group has an unconditional right to defer settlement of the liability for at least 12 months after the end of the reporting period.

Borrowing costs

Borrowing costs are recognised in the income statement in the period in which they are incurred.

Joint Share Ownership Plan ("JSOP")

On 16 August 2021, the Company issued and allotted 600,000 new ordinary shares of £0.10 each ("ordinary shares"). The new ordinary shares have been issued at a subscription price of 155p per ordinary share, being the closing price of an ordinary share on 16 August 2021, pursuant to the Helios Underwriting plc employees' Joint Share Ownership Plan (the "Plan").

The new ordinary shares have been issued into the respective joint beneficial ownership of (i) each of the participating Executive Directors as shown in Note 23 and (ii) the Trustee of JTC Employee Solutions Limited (the "Trust") and are subject to the terms of joint ownership agreements ("JOAs") respectively entered into between the Director, the Company and the Trustee. The nominal value of the new ordinary shares has been paid by the Trust out of funds advanced to it by the Company with the additional consideration of 145p left outstanding until such time as new ordinary shares are sold. The Company has waived its lien on the shares such that there are no restrictions on their transfer.

The terms of the JOAs provide, inter alia, that if jointly owned shares become vested and are sold, the proceeds of sale will be divided between the joint owners so that the participating Director receives an amount equal to the amount initially provided by the participating Director plus any growth in the market value of the jointly owned ordinary shares above a target share price of 174.8p (so that the participating Director will only ever receive value if the share sale price exceeds this).

The vesting of the award will be subject to performance conditions relating to growth in net tangible asset value per share measured over the three calendar years from the net tangible asset per share disclosed as at 31 December 2021 of 151p.

The percentage of jointly owned shares that vest shall be dependent on the average growth in net tangible asset value per share during the three financial years ending 31 December 2023. The vesting percentage shall be determined on the average growth in net tangible asset value per share. If the average growth in net tangible asset value does not exceed 5%, then no awards vest, and if the average growth in net tangible asset value exceeds 20% or above, then 100% of the awards vest.

The Plan was established and approved by resolution of the Remuneration Committee of the Company on 13 December 2017 and provides for the acquisition by employees, including Executive Directors, of beneficial interests as joint owners (with the Trust) of ordinary shares in the Company upon the terms of a JOA. The terms of the JOA provide that if the jointly owned shares become vested and are sold, the proceeds of sale will be divided between the joint owners on the terms set out above.

Long Term Incentive Plan ("LTIP")

In 2022, the Company operated the Helios Underwriting plc Long Term Incentive Plan ("LTIP"). On 16 December 2022, the Company granted 571,427 (see note 23) awards under the LTIP in the form of a nil-cost options. Under the same plan, the company granted a further 491,227 on 30 May 2023.

The awards' performance conditions set threshold (30%) to stretch (60%) targets in respect of the Company's total shareholder return ("TSR") over the three year period following the grant of the awards. No portion of the awards shall vest unless the Company's TSR at the end of the performance period reaches the threshold target, for which one quarter of the awards would vest, rising on a straight line basis to full vesting of the awards for the Company's TSR over the performance period being equal to the stretch target or better. In the case of Executive Directors, any vested shares will be subject to a two-year holding period.

On 5 April 2023 a further 875,000 awards were made under the company's LTIP, with the terms set out below.

The awards' performance conditions set threshold (50%) to stretch (100%) targets in respect of the Company's total shareholder return ("TSR") over the five year period following the grant of the awards. No portion of the awards shall vest unless the Company's TSR at the end of the performance period reaches the threshold target, for which one quarter of the awards would vest, rising on a straight line basis to full vesting of the awards for the Company's TSR over the performance period being equal to the stretch target or better. In the case of Executive Directors, any vested shares will be subject to a two-year holding period.

The awards for the Executive Directors totalled 1,937,656. The vesting period for the awards is three or five years subject to continued service and the achievement of specific performance conditions. If the options remain unexercised after a period of ten years from the date of grant, the options expire.

The fair value of the LTIP awards is calculated using a Monte Carlo (Stochastic) model taking into account the terms and conditions of the awards granted.

No options were exercised during the year.

Current and deferred tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the income statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity, in which case tax is also recognised in other comprehensive income or directly in equity, respectively.

Current tax

The current income tax charge is calculated on the basis of the tax laws enacted at the balance sheet date in the countries where the Company and its subsidiaries operate and generate taxable income. Management establishes provisions when appropriate, on the basis of amounts expected to be paid to the tax authorities.

Deferred tax

Deferred tax is provided in full on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the Financial Statements.

However, if the deferred tax arises from initial recognition of an asset or liability in a transaction other than a business combination that at the time of the transaction affects neither accounting nor taxable profit or loss, it is not accounted for.

Deferred tax is determined using tax rates (and laws) that have been enacted or substantively enacted by the end of the reporting period and are expected to apply when the related deferred income tax asset is realised or the deferred income tax liability is settled.

Deferred tax assets are recognised to the extent that it is probable that future taxable profits will be available against which the temporary differences can be utilised.

Other payables

These present liabilities for services provided to the Group prior to end of the financial year which are unpaid. These are classified as current liabilities, unless payment is not due within 12 months after the reporting date. They are recognised initially at their fair value and subsequently measured at amortised cost using the effective interest method.

Share capital and share premium

Ordinary shares are classified as equity.

The difference between the fair value of the consideration received and the nominal value of the share capital issued is taken to the share premium account. Incremental costs directly attributable to the issue of shares or options are shown in equity as a deduction, net of tax, from proceeds.

Where the Company buys back its own ordinary shares on the market, and these are held in treasury, the purchase is made out of distributable profits and hence shown as a deduction from the Company's retained earnings.

Dividend distribution policy

Dividend distribution to the Company's shareholders is recognised in the Group's and the Parent Company's Financial Statements in the period in which the dividends are approved by the Company's shareholders.

3. Key accounting judgements and estimation uncertainties

In applying the Company's accounting policies, the Directors are required to make judgements, estimates and assumptions in determining the carrying amounts of assets and liabilities. These judgements, estimates and assumptions are based on the best and most reliable evidence available at the time when the decisions are made, and are based on historical experience and other factors that are considered to be applicable. Due to the inherent subjectivity involved in making such judgements, estimates and assumptions, the actual results and outcomes may differ. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised, if the revision affects only that period, or in the period of the revision and future periods, if the revision affects both current and future periods.

The measurement of the provision for claims outstanding is the most significant judgement involving estimation uncertainty regarding amounts recognised in these Financial Statements in relation to underwriting by the syndicates and this is disclosed further in Notes 4 and 7.

The management and control of each syndicate is carried out by the managing agent of that syndicate, and the Group looks to the managing agent to implement appropriate policies, procedures and internal controls to manage each syndicate.

The key accounting judgements and sources of estimation uncertainty set out below therefore relate to those made in respect of the Group only, and do not include estimates and judgements made in respect of the syndicates.

4. Risk management

The majority of the risks to the Group's future cash flows arise from each subsidiary's participation in the results of Lloyd's syndicates. As detailed below, these risks are mostly managed by the managing agents of the syndicates. The Group's role in managing these risks, in conjunction with its subsidiaries and members' agent, is limited to a selection of syndicate participations, monitoring the performance of the syndicates and the purchase of appropriate member level reinsurance.

Risk background

The syndicate's activities expose them to a variety of financial and non-financial risks. The managing agent is responsible for managing the syndicate's exposure to these risks and, where possible, introducing controls and procedures that mitigate the effects of the exposure to risk. For the purposes of setting capital requirements for the 2020 and subsequent years of account, each managing agent will have prepared a Lloyd's Capital Return ("LCR") for the syndicate to agree capital requirements with Lloyd's based on an agreed assessment of the risks impacting the syndicate's business and the measures in place to manage and mitigate those risks from a quantitative and qualitative perspective. The risks described below are typically reflected in the LCR and typically the majority of the total assessed value of the risks concerned is attributable to insurance risk.

The insurance risks faced by a syndicate include the occurrence of catastrophic events, downward pressure on pricing of risks, reductions in business volumes and the risk of inadequate reserving. Reinsurance risk arises from the risk that a reinsurer fails to meet its share of a claim. The management of the syndicate's funds is exposed to investment risk, liquidity risk, credit risk, currency risk and interest rate risk (as detailed below), leading to financial loss. The syndicate is also exposed to regulatory and operational risks including its ability to continue to trade. However, supervision by Lloyd's and the Prudential Regulation Authority provides additional controls over the syndicate's management of risks.

The Group manages the risks faced by the syndicates on which its subsidiaries participate by monitoring the performance of the syndicates it supports. This commences in advance of committing to support a syndicate for the following year, with a review of the business plan prepared for each syndicate by its managing agent. In addition, quarterly reports and annual accounts, together with any other information made available by the managing agent, are monitored and if necessary enquired into. If the Group considers that the risks being run by the syndicate are excessive, it will seek confirmation from the managing agent that adequate management of the risk is in place and, if considered appropriate, will withdraw support from the next year of account. The Group also manages its exposure to insurance risk by purchasing appropriate member level reinsurance.

(a) Syndicate risks

(i) Liquidity risk

The syndicates are exposed to daily calls on their available cash resources, principally from claims arising from its insurance business. Liquidity risk arises where cash may not be available to pay obligations when due, or to ensure compliance with the syndicate's obligations under the various trust deeds to which it is party.

The syndicates aim to manage their liquidity position so that they can fund claims arising from significant catastrophic events, as modelled in their Lloyd's realistic disaster scenarios ("RDS").

Although there are usually no stated maturities for claims outstanding, syndicates have provided their expected maturity of future claims settlements as follows:

2023	No stated maturity £'000	0-1 year £'000	1-3 years £'000	3-5 years £'000	>5 years £'000	Total £'000
Claims outstanding	-	108,318	106,266	48,169	46,435	309,188

2022	No stated maturity £'000	0-1 year £'000	1-3 years £'000	3-5 years £'000	>5 years £'000	Total £'000
Claims outstanding	-	98,332	95,723	39,265	38,695	272,015

(ii) Credit risk

Credit ratings to syndicate assets (Note 28) emerging directly from insurance activities which are neither past due nor impaired are as follows:

2023	AAA £'000	AA £'000	A £'000	BBB or lower £'000	Not rated £'000	Total £'000
Financial investments	54,386	56,026	71,762	25,079	9,885	217,138
Deposits with ceding undertakings	-	-	261	-	45	306
Reinsurers' share of claims outstanding	1,933	32,553	44,102	53	4,314	82,955
Reinsurance debtors	363	1,245	3,084	2	341	5,035
Cash at bank and in hand	988	111	24,615	1	184	25,899
	57,670	89,935	143,824	25,135	14,769	331,333

2022	AAA £'000	AA £'000	A £'000	BBB or lower £'000	Not rated £'000	Total £'000
Financial investments	38,125	42,837	45,204	17,617	8,126	151,909
Deposits with ceding undertakings	-	-	300	-	33	333
Reinsurers' share of claims outstanding	3,478	25,787	47,259	171	3,989	80,684
Reinsurance debtors	756	674	1,957	19	226	3,632
Cash at bank and in hand	1,374	419	13,148	1	104	15,046
	43,733	69,717	107,868	17,808	12,478	251,603

Syndicate assets (Note 28) emerging directly from insurance activities, with reference to their due date or impaired, are as follows:

	Past due but not impaired
2023	Neither past due nor impaired £'000	Less than 6 months £'000	Between 6 months and 1 year £'000	Greater than 1 year £'000	Impaired £'000	Total £'000
Financial investments	217,138	-	-	-	-	217,138
Deposits with ceding undertakings	306	-	-	-	-	306
Reinsurers' share of claims outstanding	82,954	12	-	-	(18)	82,948
Reinsurance debtors	5,036	4,275	212	136	(1)	9,658
Cash at bank and in hand	25,899	-	-	-	-	25,899
Insurance and other debtors	199,880	7,496	1,904	1,195	(17)	210,458
	531,213	11,783	2,116	1,331	(36)	546,407

	Past due but not impaired
2022	Neither past due nor impaired £'000	Less than 6 months £'000	Between 6 months and 1 year £'000	Greater than 1 year £'000	Impaired £'000	Total £'000
Financial investments	151,909	-	-	-	-	151,909
Deposits with ceding undertakings	333	-	-	-	-	333
Reinsurers' share of claims outstanding	80,684	-	-	-	(18)	80,666
Reinsurance debtors	3,632	4,162	56	23	-	7,873
Cash at bank and in hand	15,046	-	-	-	-	15,046
Insurance and other debtors	163,948	5,625	1,494	717	(10)	171,774
	415,551	9,787	1,550	740	(28)	427,600

(iii) Interest rate equity price risk

Interest rate risk and equity price risk are the risks that the fair value of future cash flows of financial instruments will fluctuate because of changes in market interest rates and market prices, respectively.

(iv) Currency risk

The syndicates' main exposure to foreign currency risk arises from insurance business originating overseas, primarily denominated in US dollars. Transactions denominated in US dollars form a significant part of the syndicates' operations. This risk is, in part, mitigated by the syndicates maintaining financial assets denominated in US dollars against its major exposures in that currency.

The table below provides details of syndicate assets and liabilities (Note 28) by currency:

2023	GBP £'000	USD £'000	EUR £'000	CAD £'000	Other £'000	Total £'000
Total assets	77,449	402,699	19,131	46,009	12,653	557,941
Total liabilities	(84,389)	(377,445)	(20,791)	(33,521)	(6,941)	(523,087)
(Deficiency)/surplus of assets	(6,940)	25,254	(1,660)	12,488	5,712	34,854

2022	GBP £'000	USD £'000	EUR £'000	CAD £'000	Other £'000	Total £'000
Total assets	60,777	317,487	13,921	35,008	12,988	440,181
Total liabilities	(68,185)	(324,039)	(18,413)	(27,310)	(7,557)	(445,504)
(Deficiency)/surplus of assets	(7,408)	(6,552)	(4,492)	7,698	5,631	(5,123)

The impact of a 5% change in exchange rates between GBP and other currencies would be £2,090,000 on shareholders' funds (2022: £114,000).

(v) Reinsurance risk

Reinsurance risk to the Group arises where reinsurance contracts put in place to reduce gross insurance risk do not perform as anticipated, result in coverage disputes or prove inadequate in terms of the vertical or horizontal limits purchased. Failure of a reinsurer to pay a valid claim is considered a credit risk, which is detailed separately below.

The Group currently has reinsurance programmes on the 2021, 2022 and 2023 years of account.

The Group has strategic collateralised quota share arrangements in place in respect of its underwriting business with XL Re Limited, Bermudan reinsurer Everest Reinsurance Bermuda Limited (part of global NYSE-quoted insurer Everest Re Group Limited), Guernsey reinsurer Polygon Insurance Co Limited and other private shareholders through HIPCC Limited.

(b) Group risks - corporate level

(i) Investment, credit, liquidity and currency risks

The other significant risks faced by the Group are with regard to the investment of funds within its own custody. The elements of these risks are investment risk, liquidity risk, credit risk, interest rate risk and currency risk. To mitigate this, the surplus Group funds are deposited with highly rated banks and fund managers. The main liquidity risk would arise if a syndicate had inadequate liquid resources for a large claim and sought funds from the Group to meet the claim. In order to minimise investment risk, credit risk and liquidity risk, the Group's funds are invested in readily realisable short-term deposits. The Group's maximum exposure to credit risk at 31 December 2023 is £116.5m (2022: £90.9m), being the aggregate of the Group's insurance receivables, prepayments and accrued income, financial assets at fair value, and cash and cash equivalents, excluding any amounts held in the syndicates. The syndicates can distribute their results in sterling, US dollars or a combination of the two. The Group is exposed to movements in the US dollar between the balance sheet date and the distribution of the underwriting profits and losses, which is usually in the May following the closure of a year of account. The Group does not use derivative instruments to manage risk and, as such, no hedge accounting is applied.

As a result of the specific nature and structure of the Group's collateralised quota share reinsurance arrangements through Cell 6 (Guernsey based protected cell managed by HIPCC), the Group's funds at Lloyd's calculation benefits from an aggregate £31.6m (2022: £27.8m) letter of credit ("LOC") acceptable to Lloyd's, on behalf of XL Re Limited, Everest Reinsurance Bermuda Limited, and other private shareholders. The LOC is pledged in aggregate to the relevant syndicates through Lloyd's and thus Helios Underwriting plc is not specifically exposed to counterparty credit risk in this matter. Should the bank's LOC become unacceptable to Lloyd's for any reason, the reinsurer is responsible under the terms of the contract for making alternative arrangements. The contract is annually renewable and the Group has a contingency plan in place in the event of non-renewal under both normal and adverse market conditions.

(ii) Market risk

The Group is exposed to market and liquidity risk in respect of its holdings of syndicate participations. Lloyd's syndicate participations are traded in the Lloyd's auctions held in September and October each year. The Group is exposed to changes in market prices and a lack of liquidity in the trading of a particular syndicate's capacity could result in the Group making a loss compared to the carrying value when the Group disposes of particular syndicate participations.

(iii) Regulatory risks

The Company's subsidiaries are subject to continuing approval by Lloyd's to be a member of a Lloyd's syndicate. The risk of this approval being removed is mitigated by monitoring and fully complying with all requirements in relation to membership of Lloyd's. The capital requirements to support the proposed amount of syndicate capacity for future years are subject to the requirements of Lloyd's. A variety of factors are taken into account by Lloyd's in setting these requirements including market conditions and syndicate performance and, although the process is intended to be fair and reasonable, the requirements can fluctuate from one year to the next, which may constrain the volume of underwriting a subsidiary of the Company is able to support.

The Company is subject to the AIM Rules. Compliance with the AIM Rules is monitored by the Board.

Operational risks

As there are relatively few transactions actually undertaken by the Group, there are only limited systems and operational requirements of the Group and therefore operational risks are not considered to be significant. Close involvement of all Directors in the Group's key decision making and the fact that the majority of the Group's operations are conducted by syndicates provide control over any remaining operational risks.

Capital management objectives, policies and approach

The Group has established the following capital management objectives, policies and approach to managing the risks that affect its capital position:

• to maintain the required level of stability of the Group, thereby providing a degree of security to shareholders;

• to allocate capital efficiently and support the development of the business by ensuring that returns on capital employed meet the requirements of the shareholders; and

• to maintain the financial strength to support increases in the Group's underwriting through acquisition of capacity in the Lloyd's auctions or through the acquisition of new subsidiaries.

The Group's capital management policy is to hold a sufficient level of capital to allow the Group to take advantage of market conditions, particularly when insurance rates are improving, and to meet the funds at Lloyd's ("FAL") requirements that support the corporate member subsidiaries' current and future levels of underwriting.

Approach to capital management

The capital structure of the Group consists entirely of equity attributable to equity holders of the Company, comprising issued share capital, share premium and retained earnings as disclosed in the statements of changes in equity on pages 34 and 35

At 31 December 2023, the corporate member subsidiaries had an agreed Economic Capital Assessment ("ECA") requirement of £172.0m (2022: £125.7m) to support their underwriting on the 2023 year of account. The funds to support this requirement are held in short-term investment funds and deposits or provided by the quota share reinsurance capital providers by way of an LOC. The FAL requirements are formally assessed and funded twice yearly and must be met by the corporate member subsidiaries to continue underwriting. At 31 December 2023, the agreed ECA requirements for the Group were 35% (2022: 43%) of the capacity for the following year of account

5. Segmental information

Martin Reith is the Group's chief operating decision maker. He has determined its operating segments based on the way the Group is managed, for the purpose of allocating resources and assessing performance.

The Group has three segments that represent the primary way in which the Group is managed, as follows:

• syndicate participation;

• investment management; and

• other corporate activities.

The tables below contain the aggregated technical and non-technical accounts.

Year ended 31 December 2023	Syndicate participation £'000	Investment management £'000	Other corporate activities £'000	Total £'000
Net earned premium	212,120	-	(11,141)	200,980
Net investment income	11,204	1,855	-	13,059
Other (loss)/income	(532)	-	1,357	825
Net insurance claims and loss adjustment expenses	(106,404)	-	-	(106,404)
Expenses incurred in insurance activities	(76,985)	-	(2,251)	(79,236)
Other operating expenses	(97)	-	(7,041)	(7,138)
Amortisation of goodwill	-	-	619	619
Impairment of syndicate capacity (see Note 13)	-	-	-	-
Profit before tax	39,307	1,855	(18,457)	22,705

Year ended 31 December 2022	Syndicate participation £'000	Investment management £'000	Other corporate activities £'000	Total £'000
Net earned premium	150,393	-	-	150,393
Net investment income	(3,928)	1,152	-	(2,776)
Other income	533	-	195	728
Net insurance claims and loss adjustment expenses	(93,876)	-	(1,963)	(95,839)
Expenses incurred in insurance activities	(52,507)	-	(1,321)	(53,828)
Other operating expenses	(126)	-	(3,721)	(3,847)
Amortisation of goodwill	-	-	1,216	1,216
Impairment of syndicate capacity (see Note 13)	-	-	-	-
Loss before tax	489	1,152	(5,594)	(3,953)

The Group does not have any geographical segments as it considers all of its activities to arise from trading within the UK.

No major customers exceed 10% of revenue.

Below is an analysis of the Group underwriting by class of business:

Class of business 2023	Gross written premiums £'000	Gross premiums earned £'000	Gross claims incurred £'000	Net operating expenses £'000	Reinsurance balance £'000	Total £'000
Accident and health	4,247	3,801	(1,646)	(1,589)	(304)	262
Motor - third party liability	5,066	4,620	(3,205)	(847)	(404)	164
Motor - other classes	18,248	13,795	(8,658)	(4,300)	(1,461)	(624)
Marine, aviation and transport	19,210	17,870	(13,764)	(5,806)	697	(1,003)
Fire and other damage to property	87,169	77,541	(29,143)	(21,620)	(15,069)	11,709
Third party liability	78,291	65,628	(33,477)	(20,751)	(5,926)	5,474
Credit and suretyship	8,300	7,136	(2,732)	(2,326)	(1,130)	948
Legal expenses	138	124	(62)	(54)	(1)	7
Assistance	-	-	-	-	-	-
Miscellaneous	190	131	(107)	(84)	(2)	(62)
Total direct	220,859	190,646	(92,795)	(57,377)	(23,599)	16,875
Reinsurance inwards	86,911	86,703	(33,331)	(21,735)	(33,049)	(1,412)
Total	307,770	277,349	(126,126)	(79,112)	(56,648)	15,463

2022	Gross written premiums £'000	Gross premiums earned £'000	Gross claims incurred £'000	Net operating expenses £'000	Reinsurance balance £'000	Total £'000
Accident and health	3,552	2,871	(1,253)	(1,250)	(166)	201
Motor - third party liability	4,564	2,222	(1,391)	(502)	(133)	196
Motor - other classes	8,941	8,097	(5,241)	(2,615)	68	309
Marine, aviation and transport	15,677	12,668	(9,183)	(4,406)	1,582	661
Fire and other damage to property	64,637	52,689	(29,289)	(14,626)	(5,373)	3,401
Third party liability	55,307	43,799	(27,586)	(13,217)	(1,735)	1,261
Credit and suretyship	5,326	4,214	(2,416)	(1,255)	(148)	395
Legal expenses	120	82	(38)	(36)	4	13
Assistance	-	-	-	-	-	-
Miscellaneous	(139)	(117)	(79)	(83)	(14)	(58)
Total direct	158,263	126,759	(76,476)	(37,990)	(5,915)	6,379
Reinsurance inwards	86,352	72,134	(53,515)	(16,737)	(8,433)	(6,552)
Total	244,615	198,893	(129,991)	(54,727)	(14,348)	(172)

6. Operating (loss)/profit before impairments of goodwill and capacity

The tables below contain the aggregated technical and non-technical accounts:

	Underwriting year of account*				Pre- acquisition** £'000	Corporate reinsurance £'000	Other corporate £'000	Total £'000
Year ended 31 December 2023	2021 and prior £'000	2022 £'000	2023 £'000	Sub-total £'000	Pre- acquisition** £'000	Corporate reinsurance £'000	Other corporate £'000	Total £'000
Gross premium written	2,009	33,313	276,798	312,120	(4,350)	-	-	307,770
Reinsurance ceded	(1,494)	(6,125)	(57,624)	(65,242)	990	(11,141)	(4,138)	(79,531)
Net premium written	516	27,188	219,174	246,878	(3,360)	(11,141)	(4,138)	228,239
Net earned premium	5,799	103,291	110,350	219,440	(3,180)	(11,141)	(4,138)	200,980
Other income/(loss)	5,188	3,630	1,757	10,575	(202)	1,408	2,103	13,884
Net insurance claims incurred and loss adjustment expenses	2,528	(49,731)	(60,706)	(107,908)	1,504	-	-	(106,404)
Operating expenses	(3,735)	(31,938)	(43,732)	(79,405)	1,384	-	(8,353)	(86,374)
Operating profit/(loss) before impairments of goodwill and capacity	9,780	25,252	7,669	42,701	(494)	(9,733)	(10,388)	22,086
Quota share adjustment	(2,949)	(6,303)	(1,889)	(11,141)	-	11,141	-	-
Operating profit/(loss) before impairments of goodwill and capacity, after quota share adjustment	6,831	18,949	5,780	31,560	(494)	1,408	(10,388)	22,086

* The underwriting year of account results represent the Group's share of the syndicates' results by underwriting year of account before corporate member level reinsurance and members' agent's charges.

** Pre-acquisition relates to the element of results from the new acquisitions before they were acquired by the Group.

	Underwriting year of account*
Year ended 31 December 2022	2020 and prior £'000	2021 £'000	2022 £'000	Sub-total £'000	Pre- acquisition** £'000	Corporate reinsurance £'000	Other corporate £'000	Total £'000
Gross premium written	1,138	15,099	234,712	250,949	(6,334)	-	-	244,615
Reinsurance ceded	589	(2,994)	(54,594)	(56,999)	1,283	-	(1,261)	(56,977)
Net premium written	1,727	12,105	180,118	193,950	(5,051)	-	(1,261)	187,638
Net earned premium	5,911	56,042	94,653	156,606	(4,952)	-	(1,261)	150,393
Other (loss)/income	(2,496)	(1,046)	22	(3,520)	263	562	647	(2,048)
Net insurance claims incurred and loss adjustment expenses	3,804	(30,920)	(69,680)	(96,796)	2,887	(1,964)	33	(95,839)
Operating expenses	(2,523)	(17,172)	(34,515)	(54,210)	1,756	-	(5,220)	(57,675)
Operating profit/(loss) before impairments of goodwill and capacity	4,696	6,904	(9,520)	2,080	(46)	(1,401)	(5,802)	(5,169)
Quota share adjustment	(2,049)	(2,358)	2,443	(1,964)	-	1,964	-	-
Operating profit/(loss) before impairments of goodwill and capacity, after quota share adjustment	2,647	4,546	(7,077)	116	(46)	562	(5,801)	(5,169)

** Pre-acquisition relates to the element of results from the new acquisitions before they were acquired by the Group.

7. Insurance liabilities and reinsurance balances

Movement in claims outstanding

	Gross £'000	Reinsurance £'000	Net £'000
At 1 January 2022	186,653	53,433	133,220
Increase in reserves arising from acquisition of subsidiary undertakings	10,888	3,177	7,711
Movement of reserves	63,339	18,320	45,019
Other movements	11,135	5,796	5,339
At 31 December 2022	272,015	80,726	191,289
At 1 January 2023	272,015	80,726	191,289
Increase in reserves arising from acquisition of subsidiary undertakings	10,249	2,961	7,288
Movement of reserves	33,429	(2,000)	35,429
Other movements	(6,505)	1,321	(7,826)
At 31 December 2023	309,188	83,008	226,180

Included within other movements are the 2020 and prior years' claims reserves reinsured into the 2021 year of account on which the Group does not participate and currency exchange differences.

Movement in unearned premium

	Gross £'000	Reinsurance £'000	Net £'000
At 1 January 2022	59,611	10,538	49,073
Increase in reserves arising from acquisition of subsidiary undertakings	2,846	493	2,352
Movement of reserves	45,723	8,478	37,245
Other movements	6,483	1,824	4,660
At 31 December 2022	114,663	21,333	93,330
At 1 January 2023	114,663	21,333	93,330
Increase in reserves arising from acquisition of subsidiary undertakings	4,349	758	3,591
Movement of reserves	30,420	3,161	27,259
Other movements	(5,822)	(1,290)	(4,532)
At 31 December 2023	143,610	23,962	119,648

Included within other movements are the 2019 and prior years' claims reserves reinsured into the 2020 year of account on which the Group does not participate and currency exchange differences.

Assumptions, changes in assumptions and sensitivity

As described in Note 4, the majority of the risks to the Group's future cash flows arise from its subsidiaries' participation in the results of Lloyd's syndicates and are mostly managed by the managing agents of the syndicates. The Group's role in managing these risks, in conjunction with the Group's members' agent, is limited to a selection of syndicate participations and monitoring the performance of the syndicates and their managing agents.

The amounts carried by the Group arising from insurance contracts are calculated by the managing agents of the syndicates, derived from accounting information provided by the managing agents and reported upon by the syndicate auditors.

The key assumptions underlying the amounts carried by the Group arising from insurance contracts are:

• the claims reserves calculated by the managing agents are accurate; and

• the potential deterioration of run-off year results has been fully provided for by the managing agents.

There have been no changes in assumptions in 2023.

The amounts carried by the Group arising from insurance contracts are sensitive to various factors as follows:

• a 10% increase/decrease in the managing agents' calculation of gross claims reserves will decrease/increase the Group's pre-tax profits by £30,919,000 (2022: £27,202,000);

• a 10% increase/decrease in the managing agents' calculation of net claims reserves will decrease/increase the Group's pre-tax profits by £22,618,000 (2022: £19,129,000); and

• a 10% increase/decrease in the run-off year net claims reserves will decrease/increase the Group's pre-tax profits by £65,000 (2022: £22,000).

The 10% movement has been selected to give an indication of the possible variations in the assumptions used.

Analysis of gross and net claims development

The tables below provide information about historical gross and net claims development:

Claims development - gross

£m
Underwriting pure year*	After one year	After two years	After three years	After four years	After five years	After six years	After seven years	After eight years	After nine years	After ten years	Profit on RITC received
2014	25	42	43	41	41	41	40	40	40	40	7
2015	23	43	44	42	42	42	41	41	41		6
2016	28	55	56	55	54	54	54	54			4
2017	59	89	92	91	91	90	90				4
2018	49	82	85	83	82	83					4
2019	42	84	82	78	76						4
2020	53	91	93	90							3
2021	60	102	104
2022	96	152
2023	72

Claims development - net

£m
Underwriting pure year*	After one year	After two years	After three years	After four years	After five years	After six years	After seven years	After eight years	After nine years	After ten years	Profit on RITC received
2014	21	37	37	36	35	35	34	34	34	34	5
2015	20	37	37	37	36	35	35	35	35		4
2016	22	43	44	43	42	42	42	42			5
2017	38	58	61	59	59	58	58				3
2018	34	57	59	58	56	56					3
2019	30	60	59	57	56						5
2020	37	64	66	65							1
2021	42	74	75
2022	69	119
2023	60

* Including the new acquisitions during 2023.

At the end of the three years, syndicates are normally reinsured to close. Participations on subsequent years on syndicates may therefore change. The above table shows nine years of development and how the reinsurance to close received performed.

8. Net investment income

	Year ended 31 December 2023 £'000	Year ended 31 December 2022 £'000
Investment income	6,026	2,350
Realised losses on financial assets at fair value through profit or loss	(407)	(1,021)
Unrealised profits/(losses) on financial assets at fair value through profit or loss	5,570	(4,490)
Investment management expenses	(166)	(134)
Bank interest	2,036	519
Net investment income/(loss)	13,059	(2,776)

Net investment income/(loss) shown above includes both Technical and Non-Technical investment income/(loss).

9. Operating expenses (excluding goodwill and capacity impairment)

	Year ended 31 December 2023 £'000	Year ended 31 December 2022 £'000
Expenses incurred in insurance activities:
Acquisition costs	61,964	47,897
Change in deferred acquisition costs	(7,038)	(10,163)
Administrative expenses	22,903	15,287
Other	1,407	807
	79,236	53,828
Other operating expenses:
- exchange differences	181	(644)
- Directors' remuneration	1,938	718
- staff costs	852	196
- acquisition costs in connection with the new subsidiaries acquired in the year	276	422
- bank charges	40	292
- loan interest and charges	1,721	891
- professional fees	1,611	1,662
- administration and other expenses	357	144
Auditors' remuneration:
- audit of the Parent Company and Group Financial Statements	62	56
- audit of subsidiary company Financial Statements	76	63
- audit related assurance services	24	46
	7,138	3,846
Operating expenses	86,374	57,675

The Group has eleven employees other than the Directors of the Company.

Details of the Directors' remuneration are disclosed below:

Directors' remuneration	Year ended 31 December 2023 £	Year ended 31 December 2022 £
Arthur Manners	490,000	182,000
Edward William Fitzalan-Howard (resigned 19 April 2024)	30,000	30,000
Michael Cunningham (resigned 29 June 2023)	20,000	40,000
Andrew Christie	33,000	33,000
Nigel Hanbury	450,000	208,000
Martin Reith	840,000	200,000
Tom Libassi	25,000	25,000
Michael Wade (appointed 29 June 2023)	50,000	-
Total	1,938,000	718,000

The Deputy Chairman, Nigel Hanbury, the Chief Executive Officer, Martin Reith, and the Finance Director, Arthur Manners, had a bonus incentive scheme during 2023 in addition to their basic remuneration. The above figures for Nigel Hanbury, Martin Reith and Arthur Manners include an accrual for the year of £225,000, 550,000 (of which £100,000 is deferred and 295,000 (of which £100,000 is deferred) respectively (2022: £48,000 for Nigel Hanbury and £42,000 Arthur Manners) in respect of this scheme. The deferred bonus will be used as notional underwriting capital in a proposed staff underwriting corporate member.

No other Directors derive other benefits, pension contributions or incentives from the Group. Nigel Hanbury, Martin Reith and Arthurs Manners have share interests in the Joint Share Ownership Plan and the Long Term Incentive Plan (see Note 23).

10. Income tax charge

(a) Analysis of tax charge/(credit) in the year

	Year ended 31 December 2023 £'000	Year ended 31 December 2022 £'000
Current tax:
- current year	84	(84)
- prior year	427	(53)
- foreign tax paid	153	5
Total current tax	664	(132)
Deferred tax:
- current year	4,958	(1,564)
- prior year	712	(156)
Total deferred tax	5,670	(1,720)
Income charge/(credit) credit	6,334	(1,852)

(b) Factors affecting the tax credit for the year

Tax for the year is 25% (2022: 19%), the same as the standard rate of corporation tax in the UK of 25% (2022: 19%).

The differences are explained below:

	Year ended 31 December 2023 £'000	Year ended 31 December 2022 £'000
Profit/(loss) before tax	22,705	(5,169)
Tax calculated as loss before tax multiplied by the standard rate of corporation tax in the UK of 25% (2022: 19%)	5,676	(982)
Tax effects of:
- prior year adjustments	(1,038)	(209)
- rate change and other adjustments	2,405	(502)
- permanent disallowances	(857)	(164)
- foreign taxes	153	5
- other	335	-
Tax charge/(credit) for the year	6,334	(1,852)

The results of the Group's participation on the 2021, 2022 and 2023 years of account and the calendar year movement on 2020 and prior run-offs will not be assessed for tax until the years ended 2024, 2025 and 2026 respectively, being the year after the calendar year result of each run-off year or the normal date of closure of each year of account. Full provision is made as part of the deferred tax provisions for underwriting profits/(losses) not yet subject to corporation tax.

11. Earnings per share

Basic earnings per share is calculated by dividing the net profit attributable to ordinary equity holders of the Company after tax by the weighted average number of ordinary shares outstanding during the period.

Diluted earnings per share is calculated by dividing the net profit attributable to ordinary equity holders of the Company by the weighted average number of ordinary shares outstanding during the year, plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares.

The earnings per share and weighted average number of shares used in the calculation are set out below:

	Year ended 31 December 2023	Year ended 31 December 2022
Profit/(loss) for the year after tax attributable to ordinary equity holders of the Parent	£16,371,000	£(2,101,000)
Basic - weighted average number of ordinary shares*	75,933,065	68,168,599
Diluted - weighted average number of ordinary shares* (includes LTIP and JSOP - see Note 23)	78,533,619	69,292,082
Basic profit/(loss) per share	21.56p	(3.08)p
Diluted profit/(loss) per share**	20.85p	(3.08)p

* Used as the denominator in calculating the basic earnings per share, and diluted earnings per share, respectively.

** Diluted loss per share is not permitted to be reduced from the basic loss per share.

12. Dividends paid or proposed

A dividend of £2,319,000 was paid during the year (2022: £2,034,000).

A final dividend of 6p is being proposed in respect of the financial year ended 31 December 2023.

13. Intangible assets

	Positive Goodwill £'000	Negative Goodwill £'000	Syndicate capacity £'000	Total £'000
Cost
At 1 January 2023	553	(3,267)	59,966	57,252
Additions	57	(405)	500	152
Disposals	-	-	(5)	(5)
Acquired with subsidiary undertakings	-	-	3,988	3,988
Revaluation	-	-	17,987	17,987
At 31 December 2023	610	(3,672)	82,436	79,374
Amortisation
At 1 January 2023	71	(2,194)	-	(2,123)
Charge for the period	191	(811)	-	(620)
Disposals	-	-	-	-
Acquired with subsidiary undertakings	-	-	-	-
At 31 December 2023	262	(3005)	-	(2,743)
Net Book Value
At 31 December 2022	482	(1,073)	59,966	59,375
At 31 December 2023	348	(667)	82,436	82,117

Note 22 sets out the details of the entities acquired by the Group during the year, the fair value adjustments and the goodwill arising.

The cost value of the Syndicate Capacity before revaluation is £47,986,000 (2022: £43,503,000).

14. Investments in subsidiaries

	31 December 2023 £'000	31 December 2022 £'000
Total	80,005	65,546

During 2023 a reverse impairment charge of £8,063,000 was recognised on the cost of investments in subsidiaries and included in the Parent income statement.

In addition, the company acquired four new subsidiaries for a total cash consideration of £7,244,000 and the issue of 123,457 Ordinary 10p shares for a total value of £200,000. The company also sold four existing dormant subsidiaries for a total proceeds of £Nil.

At 31 December 2023 the Company owned 100% of the following companies and limited liability partnerships, either directly or indirectly. All subsidiaries are incorporated in England and Wales and their registered office address is at 40 Gracechurch Street, London EC3V 0BT, apart from RBC CEES Trustee Limited, which is incorporated in Jersey and its registered office address is Gaspé House, 66-72 Esplanade, Jersey JE2 3QT and Gould Scottish Partnership, which is incorporated in Scotland and its registered office is 9 Haymarket Square, Edinburgh, EH3 8RY.

Company or partnership	Direct/indirect interest	2023 ownership	2022 ownership	Principal activity
Nameco (No. 917) Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Nameco (No. 346) Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Charmac Underwriting Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
RBC CEES Trustee Limited(ii)	Direct	100%	100%	Joint Share Ownership Plan
Chapman Underwriting Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Advantage DCP Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Romsey Underwriting Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Helios UTG Partner Limited(i)	Direct	100%	100%	Corporate partner
Salviscount LLP	Indirect	100%	100%	Lloyd's of London corporate vehicle
Inversanda LLP	Indirect	100%	100%	Lloyd's of London corporate vehicle
Fyshe Underwriting LLP	Indirect	100%	100%	Lloyd's of London corporate vehicle
Nomina No 505 LLP	Indirect	100%	100%	Lloyd's of London corporate vehicle
Nomina No 321 LLP	Indirect	100%	100%	Lloyd's of London corporate vehicle
Nameco (No. 409) Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Nameco (No. 1113) Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Catbang 926 Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Whittle Martin Underwriting	Direct	100%	100%	Lloyd's of London corporate vehicle
Nameco (No. 408) Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Nomina No 084 LLP	Indirect	100%	100%	Lloyd's of London corporate vehicle
Nameco (No. 510) Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Nameco (No. 544) Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
N J Hanbury Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Nameco (No. 1011) Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Nameco (No. 1111) Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Nomina No 533 LLP	Indirect	100%	100%	Corporate partner
North Breache Underwriting Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
G T C Underwriting Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Hillnameco Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Nameco (No. 2012) Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Nameco (No. 1095) Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
New Filcom Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Kemah Lime Street Capital	Direct	100%	100%	Lloyd's of London corporate vehicle
Nameco (No. 1130) Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Nomina No 070 LLP	Indirect	100%	100%	Corporate partner
Nameco (No. 389) Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Nomina No. 469 LLP	Indirect	100%	100%	Corporate partner
Nomina No. 536 LLP	Indirect	100%	100%	Corporate partner
Nameco (No. 301) Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Nameco (No. 1232) Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Shaw Lodge Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Queensberry Underwriting	Direct	100%	100%	Lloyd's of London corporate vehicle
Nomina No 472 LLP	Indirect	100%	100%	Corporate partner
Nomina No 110 LLP	Indirect	100%	100%	Corporate partner
Chanterelle Underwriting Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Kunduz LLP	Indirect	100%	100%	Corporate partner
Exalt Underwriting Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Nameco (No. 1110) Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Clifton 2011 Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Nomina No 378 LLP	Indirect	100%	100%	Corporate partner
Gould Scottish Limited Partnership	Indirect	100%	100%	Corporate partner
Harris Family UTG Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Whitehouse Underwriting Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Risk Capital UTG Limited	Direct	100%	100%	Lloyd's of London corporate vehicle
Nameco (No. 606) Limited	Direct	100%	-	Lloyd's of London corporate vehicle
Nameco (No. 1208) Limited	Direct	100%	-	Lloyd's of London corporate vehicle
Chorlton Underwriting Limited	Direct	100%	-	Lloyd's of London corporate vehicle
Park Farm Underwriting Limited	Direct	100%	-	Lloyd's of London corporate vehicle
Helios LLV One Limited	Direct	100%	-	Lloyd's of London corporate vehicle
Helios LLV Two Limited	Direct	100%	-	Lloyd's of London corporate vehicle
Helios LLV Three Limited	Direct	100%	-	Lloyd's of London corporate vehicle
Helios LLV Four Limited	Direct	100%	-	Lloyd's of London corporate vehicle
Helios LLV Five Limited	Direct	100%	-	Lloyd's of London corporate vehicle
Helios LLV Six Limited	Direct	100%	-	Lloyd's of London corporate vehicle
Helios LLV Seven Limited	Direct	100%	-	Lloyd's of London corporate vehicle
Helios LLV Eight Limited	Direct	100%	-	Lloyd's of London corporate vehicle
Helios LLV Nine LLP	Indirect	100%	-	Corporate partner
Helios LLV Ten LLP	Indirect	100%	-	Corporate partner

For details of all new acquisitions made during the year 2023, refer to Note 22(a).

(i) Helios UTG Partner Limited, a subsidiary of the Company, owns 100% of Salviscount LLP, Inversanda LLP, Fyshe Underwriting LLP, Nomina No 505 LLP, Nomina No 321 LLP Nomina No 084 LLP, Nomina No 533 LLP, Nomina No 070 LLP, Nomina No 469 LLP, Nomina No 536 LLP, Nomina No 472 LLP, Nomina No 110 LLP, Kunduz LLP. Nomina No 348 LLP and Gould Scottish Limited Partnership. The cost of acquisition of these LLPs is accounted for in Helios UTG Partner Limited, their immediate parent company.

(ii) RBC CEES Trustee Limited was an incorporated entity in year 2017 to satisfy the requirements of the Joint Share Ownership Plan (see Note 23).

15. Financial assets at fair value through profit or loss

The Group uses the following hierarchy for determining and disclosing the fair value of financial instruments by valuation technique:

Level 1: The fair value of financial instruments traded in active markets (such as publicly traded securities) is based on quoted market prices (unadjusted) at the end of the reporting period. The quoted market price used for financial assets held by the Group is the current bid price. These instruments are included in Level 1.

Level 2: The fair value of financial instruments that are not traded in an active market is determined using valuation techniques which maximise the use of observable market data inputs, either directly or indirectly (other than quoted prices included within Level 1) and rely as little as possible on entity-specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is included in Level 2.

Level 3: If one or more of the significant inputs is not based on observable market data, the instrument is included in Level 3. This is the case for unlisted equity securities.

The Group held the following financial assets carried at fair value on the statement of financial position:

Group	Total 2023 £'000	Level 1 £'000	Level 2 £'000	Level 3 £'000
Shares and other variable yield securities and units in unit trusts	33,945	9,497	20,809	3,639
Debt securities and other fixed income securities	180,208	48,831	131,378	-
Participation in investment pools	1,459	1,037	407	15
Loans and deposits with credit institutions	1,448	1,446	-	3
Derivatives	78	31	46	-
Other investments	1,120	1,120	-	-
Funds at Lloyd's	69,939	69,939	-	-
Total - fair value	288,198	131,901	152,639	3,657

Group	Total 2022 £'000	Level 1 £'000	Level 2 £'000	Level 3 £'000
Shares and other variable yield securities and units in unit trusts	18,751	3,794	12,913	2,044
Debt securities and other fixed income securities	132,031	39,187	92,844	-
Participation in investment pools	597	112	462	23
Loans and deposits with credit institutions	263	73	-	190
Derivatives	267	146	121	-
Other investments	1,064	1,064	-	-
Funds at Lloyd's	73,040	73,040	-	-
Total - fair value	226,013	117,416	106,340	2,257

Funds at Lloyd's represent assets deposited with the corporation of Lloyd's to support the Group's underwriting activities as described in the accounting policies. The Group entered into a Lloyd's Deposit Trust Deed which gives Lloyd's the right to apply these monies in settlement of any claims arising from the participation on the syndicates. These monies can only be released from the provision of this Deed with Lloyd's express permission and only in circumstances where the amounts are either replaced by an equivalent asset, or after the expiration of the Group's liabilities in respect of its underwriting.

The Directors consider any credit risk or liquidity risk not to be material.

Company

Financial assets at fair value through profit or loss are shown below:

	31 December 2023 £'000	31 December 2022 £'000
Holdings in collective investment schemes - Level 2	898	731
Total - market value	898	731

16. Other receivables

Group	31 December 2023 £'000	31 December 2022 £'000
Arising out of direct insurance operations	85,360	64,852
Arising out of reinsurance operations	63,563	59,714
Other debtors	24,009	23,110
Total	172,932	147,676

The Group has no analysis of other receivables held directly by the syndicates on the Group's behalf (see Note 27). None of the Group's other receivables are past their due date and all are classified as fully performing.

Included within the above receivables are amounts totalling £nil (2022: £nil) which are not expected to be wholly recovered within one year.

Company	31 December 2023 £'000	31 December 2022 £'000
Receivables from subsidiaries (Note 25)	70,062	73,505
Other debtors	2,463	1,278
Prepayments	1,595	-
Total	74,120	74,783

Included within receivables are amounts totalling £nil (2022: £100,000), which are not expected to be recoverable within one year.

17. Deferred acquisition costs

Group	31 December 2023 £'000	31 December 2022 £'000
At 1 January	24,991	13,615
Increase arising from acquisition of subsidiary undertakings (Note 22)	781	664
Movement in deferred acquisition costs	7,038	10,163
Other movements	(519)	549
At 31 December	32,291	24,991

18. Deferred tax

Group

Deferred tax is calculated in full on temporary differences using a tax rate of 25% on deferred tax assets and deferred tax liabilities (2022: 25% on deferred tax assets and deferred tax liabilities). The movement on the deferred tax liability account is shown below:

Deferred tax liabilities	Valuation of capacity £'000	Timing differences on underwriting results £'000	Total £'000
At 1 January 2022	13,341	(1,375)	11,965
On acquisition of subsidiary undertakings	686	(287)	399
Revaluation of capacity	668	-	668
Prior period adjustment	(156)	-	(156)
Credit for the year	(400)	(1,163)	(1,564)
At 31 December 2022	14,139	(2,828)	11,311
At 1 January 2023	14,139	(2,828)	11,311
On acquisition of subsidiary undertakings	856	-	856
Revaluation of capacity	4,497	-	4,497
Prior period adjustment	712	-	712
Charge/(credit) for the year	(67)	5,025	4,958
At 31 December 2023	20,136	2,199	22,334

Company

The Company had no deferred tax assets or liabilities (2022: £nil), as disclosed in Note 10.

19. Borrowings

Group and Company	31 December 2023 £'000	31 December 2022 £'000
Secured - at amortised cost	59,055	-
Bank revolving credit facility	-	15,000
	59,055	15,000
Current	-	15,000
Non-current	59,055	-
	59,055	15,000

Bank loan

(a) Revolving credit/loan facility

On 21 December 2021, a new sterling revolving loan facility ("RLF") was agreed with Barclays Bank Plc to the value of £15m. The interest is 4.2% per annum. On 21 March 2022, the full £15m was drawn down and on the 18 December 2023 the loan was repaid in full.

On 15 December 2023 the Company secured an A - / stable rating from Kroll Bond Rating Agency LLC, (KBRA) for up to US$100m
seven-year unsecured debt at a fixed coupon of 9.5%. An initial tranche of US75m of the debt was drawn down on 15 December 2023. The loan is repaid as one payment in full at the end of the seven year term.

Reconciliation of movements of liabilities to cash flows arising from financing activities:

The facility is secured over the assets of the Company.

	Liabilities	Equity
Group	Other loans and borrowings £'000	Share capital/ premium £'000	Other reserves £'000	Retained earnings £'000	Total £'000
Balance at 1 January 2022	-	93,261	(110)	14,595	107,746
Changes from financing cash flows
Proceeds from issue of share capital (Note 21)	-	12,781	-	-	12,781
Proceeds from loans and borrowings	-	-	-	-	-
Payments for Company buyback of ordinary shares (Note 24)	15,000	-	-	-	15,000
Repayment of borrowings	-	-	-	-	-
Dividend paid	-	-	-	(2,034)	(2,034)
Total changes from financing cash flows	15,000	12,781	-	(2,034)	25,747
Effect of changes in foreign exchange rates	-	-	-	-	-
Changes in fair value	-	-	-	-	-
Other changes:
Liability related	-	-	-	-	-
Other expense	-	-	-	-	-
Interest expense	-	-	-	-	-
Interest paid	-	-	-	-	-
Total liability related other changes	-	-	-	-	-
Total equity related other changes	-	-	-	(1,315)	(1,315)
Balance at 31 December 2022	15,000	106,042	(110)	11,246	132,178

* The equity related other changes relate to the consolidated profit for the year 2022.

	Liabilities	Equity
Group	Other loans and borrowings £'000	Share capital/ premium £'000	Other reserves £'000	Retained earnings £'000	Total £'000
Balance at 1 January 2023	15,000	106,042	(110)	9,187	130,119
Changes from financing cash flows
Proceeds from issue of share capital (Note 21)	-	349	300	-	649
Proceeds from loans and borrowings	59,055	-	-	-	59,055
Payments for Company buyback of ordinary shares (Note 24)	-	-	-	(3,209)	(3,209)
Repayment of borrowings	(15,000)	-	-	-	(15,000)
Dividend paid	-	-	-	(2,319)	(2,319)
Total changes from financing cash flows	44,055	349	300	(5,528)	39,176
Effect of changes in foreign exchange rates	-	-	-	-	-
Changes in fair value
Other changes:
Liability related	-	-	-	-	-
Other expense	-	-	-	-	-
Interest expense	-	-	-	-	-
Interest paid	-	-	-	-	-
Total liability related other changes	-	-	-	-	-
Total equity related other changes*	-	-	-	29,861	29,861
Balance at 31 December 2023	59,055	106,391	190	33,520	199,156

* The equity related other changes relate to the consolidated profit for the year 2023.

	Liabilities	Equity
Company	Other loans and borrowings £'000	Share capital/ premium £'000	Other reserves £'000	Retained earnings £'000	Total £'000
Balance at 1 January 2022	-	93,261	-	27,112	120,373
Changes from financing cash flows
Proceeds from issue of share capital (Note 21)	-	12,781	-	-	12,781
Proceeds from loans and borrowings	15,000	-	-	-	15,000
Payments for Company buyback of ordinary shares (Note 24)	-	-	-	-	-
Repayment of borrowings	-	-	-	-	-
Dividend paid	-	-	-	(2,034)	(2,034)
Total changes from financing cash flows	15,000	12,781	-	(2,034)	25,747
Effect of changes in foreign exchange rates	-	-	-	-	-
Changes in fair value	-	-	-	-	-
Other changes:	-	-	-	-	-
Liability related	-	-	-	-	-
Other expense	-	-	-	-	-
Interest expense	-	-	-	-	-
Interest paid	-	-	-	-	-
Total liability related other changes	-	-	-	-	-
Total equity related other changes*	-	-	-	(842)	(842)
Balance at 31 December 2022	15,000	106,042	-	24,236	145,278

* The equity related other changes relate to the Company's profit for the year 2022.

	Liabilities	Equity
Company	Other loans and borrowings £'000	Share capital/ premium £'000	Other reserves £'000	Retained earnings £'000	Total £'000
Balance at 1 January 2023	15,000	106,042	-	24,236	145,278
Changes from financing cash flows
Proceeds from issue of share capital (Note 21)	-	349	300	-	649
Proceeds from loans and borrowings	59,055	-	-	-	59,055
Payments for Company buyback of ordinary shares (Note 24)	-	-	-	(3,209)	(3,209)
Repayment of borrowings	(15,000)	-	-	-	(15,000)
Dividend paid	-	-	-	(2,319)	(2,319)
Total changes from financing cash flows	44,055	349	300	(5,528)	39,176
Effect of changes in foreign exchange rates	-	-	-	-	-
Changes in fair value	-	-	-	-	-
Other changes:	-	-	-	-	-
Liability related	-	-	-	-	-
Other expense	-	-	-	-	-
Interest expense	-	-	-	-	-
Interest paid	-	-	-	-	-
Total liability related other changes	-	-	-	-	-
Total equity related other changes*	-	-	-	2,318	2,318
Balance at 31 December 2023	59,055	106,391	300	21,026	186,772

* The equity related other changes relate to the Company's profit for the year 2023.

20. Other payables

Group	31 December 2023 £'000	31 December 2022 £'000
Arising out of direct insurance operations	3,925	3,509
Arising out of reinsurance operations	52,770	42,700
Corporation tax payable	-	-
Other creditors	13,899	8,684
	70,594	54,893

The Group has no analysis of other payables held directly by the syndicates on the Group's behalf (see Note 27).

Company	31 December 2023 £'000	31 December 2022 £'000
Payable to subsidiaries	5,532	3,128
Other creditors	93	-
Accruals and deferred income	3,222	2,002
	8,847	5,130

All payables above are due within one year.

21. Share capital and share premium

	Number of shares (i)	Ordinary share capital £'000	Partly paid ordinary share capital £'000	Share premium £'000	Total £'000
Ordinary shares of 10p each and share premium at 31 December 2022	77,737,372	7,664	110	98,268	106,042
Ordinary shares of 10p each and share premium at 31 December 2023	77,945,833	7,665	110	98,597	106,391

During the year, the Company issued a further 208,461 ordinary shares of 10p each. Of the shares issued, 85,004 were in relation to a script dividend and 123,457 were issued in relation to the acquisition of Chorlton Underwriting Limited. Nil proceeds were received by the company for the issue all these shares.

(i) Number of shares

	2023	2022
Allotted, called up and fully paid ordinary shares:
- on the market	74,186,068	76,218,203
- Company buyback of ordinary shares held in treasury (Note 24)	2,659,765	419,169
	76,845,833	76,637,372
Uncalled and partly paid ordinary shares under the JSOP scheme (ii) (Note 23)	1,100,000	1,100,000
	77,945,833	77,737,372

(ii) The partly paid ordinary shares are not entitled to dividend distribution rights during the year.

22. Acquisition of Limited Liability Vehicles

Acquisitions of Limited Liability Vehicles are accounted for using the acquisition method of accounting.

Where the comparison of the consideration paid to the fair value of net assets acquired gives rise to goodwill, this is taken to the consolidated statement of financial position and amortised on a straight line basis over three years. The below table shows the summary of the gain on bargain purchase and the impairment of goodwill as follows:

(a) 2023 acquisitions

During the year, the Company has acquired the following Lloyd's Limited Liability Vehicles either directly, or indirectly:

	Nameco (No. 606) Limited £'000	Nameco (No. 1208) Limited £'000	Chorlton UW Limited £'000	Park Farm UW Limited £'000	Total £'000
2023 acquisition date	2 June	12 June	14 July	20 July
Intangible assets	97	4	-	124	225
Uplift to fair value	761	717	1,227	1,100	3,805
Deferred tax on uplift to fair value	(190)	(179)	(315)	(179)	(863)
	668	542	912	1,045	3,167
Financial investments	1,910	882	2,234	2,360	7,386
Deferred income tax asset	-	-	-	-	-
Reinsurers' share of insurance liabilities:	-	-	-	-	-
- reinsurers' share of outstanding claims	421	512	1,050	979	2,962
- reinsurers' share of unearned premium	313	96	172	176	757
Other receivables, including insurance receivables	1,983	832	2,382	3,293	8,490
Deferred acquisition costs	243	98	217	224	782
Prepayments and accrued income	14	8	15	16	53
Cash and cash equivalents	108	84	201	311	704
Insurance liabilities:	-	-	-	-	-
- claims outstanding	(1,683)	(1,722)	(3,402)	(3,443)	(10,250)
- unearned premiums	(1,882)	(563)	(915)	(989)	(4,349)
Deferred income tax liabilities	-	-	-	-	-
Other payables, including insurance payables	(923)	(655)	(611)	(545)	(2,734)
Accruals and deferred income	(60)	(27)	(85)	(53)	(225)
Total fair value acquired	1,112	87	2,170	3,374	6,743
Net consideration	1,169	-	1,997	3,229	6,395
Positive goodwill on acquisition	57	-	-	-	57
Negative goodwill on acquisition	-	(87)	(173)	(145)	(404)
Since date of acquisition
Net earned premium	917	839	738	811	3,305
Profit/(loss)	79	132	77	112	400
Capacity acquired
2021 underwriting year	1,465	1,504	1,625	1,874	6,468
2022 underwriting year	1,708	1,526	1,707	1,931	6,872
2023 underwriting year	2,024	1,777	2,065	2,265	8,131

(b) 2022 acquisitions

In 2022 the Company acquired three Limited Liability Vehicles, all of which are incorporated in England and Wales and are corporate members of Lloyd's.

	Harris Family UTG Limited £'000	Whitehouse Underwriting Limited £'000	Risk Capital UTG Limited £'000	Total £'000
2022 acquisition date	6 Dec	29 Dec	31 Dec
Intangible assets	23	1	46	70
Uplift to fair value	216	503	2,025	2,744
Deferred tax on uplift to fair value	(54)	(126)	(509)	(689)
	185	378	1,562	2,125
Financial investments	501	1,212	4,303	6,016
Deferred income tax asset	-	-	-	-
Reinsurers' share of insurance liabilities:
- reinsurers' share of outstanding claims	367	617	2,192	3,176
- reinsurers' share of unearned premium	50	103	340	493
Other receivables, including insurance receivables	992	845	7,349	9,186
Deferred acquisition costs	70	125	470	665
Prepayments and accrued income	6	6	41	53
Cash and cash equivalents	66	57	445	568
Insurance liabilities:
- claims outstanding	(1,020)	(1,938)	(7,929)	(10,887)
- unearned premiums	(281)	(528)	(2,037)	(2,846)
Deferred income tax liabilities	-	-	-	-
Other payables, including insurance payables	(993)	(505)	(5,817)	(7,315)
Accruals and deferred income	(32)	(54)	(119)	(205)
Total fair value acquired	(89)	318	800	1,029
Net consideration	-	427	976	1,403
Positive goodwill on acquisition	89	109	176	374
Negative goodwill on acquisition	-	-	-	-
Since date of acquisition
Net earned premium	30	5	-	35
Profit/(loss)	(5)	-	-	(5)
Capacity acquired
2020 underwriting year	504	899	4,156	5,559
2021 underwriting year	518	902	4,360	5,780
2022 underwriting year	540	952	4,185	5,677

Had the Limited Liability Vehicles been consolidated from 1 January 2023, the consolidated statement of comprehensive income would show a net earned premium of £204,195,000 and a profit after tax of £17,981,000.

Costs incurred in connection with the three acquisitions totalling £40,000 (2022: £38,000) have been recognised in the consolidated statement of comprehensive income.

23. Share option plans

(i) Joint Share Ownership Plan ("JSOP")

500,000 shares have been vested as at 31 December 2021.

On 16 August 2021, a further 600,000 shares were issued.

Effect of the transactions

The beneficial interests of the Executives are as follows:

	2023			2022
Director	Interests in jointly owned ordinary shares issued under JSOP	Other interests in ordinary shares	Total shareholding	Interests in jointly owned ordinary shares issued under JSOP	Other interests in ordinary shares	Total shareholding
Arthur Manners	477,500	720,009	1,197,509	477,500	720,009	1,197,509
Nigel Hanbury	622,500	8,939,858	9,562,358	622,500	8,939,858	9,562,358

The JSOP is to be accounted for as if it were a premium priced option, and, therefore, Black Scholes mathematics have been applied to determine the fair value. As the performance condition will eventually be trued up, a calculation of the fair value based on an algebraic Black Scholes calculation of the value of the "as if" option discounted for the risk of forfeiture or non-vesting is reasonable. The discount factors are for the risk that an employee leaves and forfeits the award or the failure to meet the performance condition with the result the JSOP awards do not vest in full or at all.

This gave rise to a total fair value amount of £23,148 to be charged as an expense in the statement of comprehensive income and spread over three years, being £7,716 in 2018, £7,716 in 2019 and £7,716 in 2020.

(ii) Share-based payments

In 2022, the Company operated the Helios Underwriting plc Long Term Incentive Plan ("LTIP"). On 16 December 2022, the Company granted 571,427 awards under the LTIP in the form of a nil-cost options. Under the same plan, the company granted 491,227 on 30 May 2023.

The awards' performance conditions set threshold (30%) to stretch (60%) targets in respect of the Company's total shareholder return ("TSR") over the three-year period following the grant of the awards. No portion of the awards shall vest unless the Company's TSR at the end of the performance period reaches the threshold target, for which one quarter of the awards would vest, rising on a straight line basis to full vesting of the awards for the Company's TSR over the performance period being equal to the stretch target or better. In the case of Executive Directors, any vested shares will be subject to a two-year holding period.

On 5 April 2023 a further 875,000 awards were made under the company's LTIP, with the terms set out below.

The awards for the Executive Directors are as follows:

Director	As at 1 January 2023	Awards granted during 2023	Forfeited	Vested/ exercised	Outstanding at 31 December 2023	Exercisable at 31 December 2023
Arthur Manners	266,666	228,070	-	-	494,736	-
Nigel Hanbury	304,761	263,157	-	-	567,918	-
Martin Reith	-	875,000	-	-	875,000	-

The fair value of the LTIP awards is calculated using a Monte Carlo (Stochastic) model taking into account the terms and conditions of the awards granted. Each award gives rise to a fair value amount to be charged as an expense in the statement of comprehensive income and spread over a period as detailed below:

Director	16 December 2022	5 April 2023	30 May 2023	Total
Number of awards granted	571,427	875,000	491,227	1,937,656
The weighted average remaining life of the options	8.86	9.26	9.41
Period of expense
2022	5,123	-	-	5,123
2023	124,667	78,170	71,464	274,301
2024	125,008	105,573	122,223	352,804
2025	119,202	105,285	121,889	346,376
2026	-	105,285	50,424	155,709
2027	-	105,285	-	105,285
2028	-	27,402	-	27,402
Total	374,000	527,000	366,000	1,267,000

24. Treasury shares: purchase of own shares

The Company has in previous years bought back some of its own ordinary shares on the market and these are held in treasury. During 2023, the Company has bought back a further 2,240,596 shares for a total consideration of £3,209,000.

The retained earnings have been reduced by a further £3,736,000, being the consideration paid on the market for these shares, as shown in the consolidated and Parent Company statements of changes in equity.

The Company cannot exercise any rights over these bought back and held in treasury shares, and has no voting rights. No dividend or other distribution of the Company's assets can be paid to the Company in respect of the treasury shares that it holds.

As at 31 December 2023, the 2,659,765 own shares bought back represent 3.46% of the total allotted, called up and fully paid ordinary shares of the Company of 76,845,833 (Note 21).

25. Related party transactions

Helios Underwriting plc has inter-company loans with its subsidiaries which are repayable on three months' notice provided it does not jeopardise each company's ability to meet its liabilities as they fall due. All inter-company loans are, therefore, classed as falling due within one year. The amounts from/(to) subsidiaries exceeding £1m as at 31 December are set out below:

Company	31 December 2023 £'000	31 December 2022 £'000
Nameco (No. 917) Limited	9,355	12,116
Helios UTG Partner Limited	13,618	8,276
Chapman Underwriting Limited	9,663	13,458
Romsey Underwriting Limited	7,001	8,790
Advantage DCP Limited	(1,699)	(1,659)
Catbang 926 Limited	6,378	7,466
N J Hanbury Limited	2,759	2,789
Queensberry Underwriting Limited	3,164	2,870
Chanterelle Underwriting Limited	1,892	1,838
Clifton 2011 Limited	2,089	1,175
Exalt Underwriting Limited	2,132	1,268
Northbreache Underwriting Limited	-	1,119
Harris Family UTG Limited	1,479	583
Risk Capital UTG Limited	2,282	3,624
Nameco (No. 1208) Limited	1,261	-
Park Farm Underwriting Limited	(1,578)	-
Subsidiaries below £1,000,000	4,734	7,247
Net amount	64,530	70,377
Receivable from subsidiaries	70,062	73,505
Payable from subsidiaries	(5,532)	(3,128)
	64,533	70,377

The Group has entered into quota share reinsurance contracts for the 2021, 2022, 2023 and 2024 years of account with HIPCC Limited. The Limited Liability Vehicles' underwriting year of account quota share participations are set out below:

Company or partnership	2021	2022	2023	2024
Nameco (No. 917) Limited	59%	44%	36%	33%
Nameco (No. 346) Limited	60%	65%	38%	31%
Chapman Underwriting Limited	68%	11%	20%	17%
Advantage DCP Limited	54%	-	-	-
Romsey Underwriting Limited	48%	37%	29%	25%
Nomina No 321 LLP	35%	-	-	-
Nameco (No. 409) Limited	44%	-	-	-
Nameco (No. 1113) Limited	46%	-	-	-
Catbang 926 Limited	60%	21%	16%	13%
Whittle Martin Underwriting	48%	-	-	-
Nameco (No. 408) Limited	53%	-	-	-

Nigel Hanbury, a Director of Helios Underwriting plc and its subsidiary companies, was also a director and majority shareholder in HIPCC Limited until 29 November 2023 when he sold his majority shareholding in full, and resigned as a director on the same date. Under the agreement, the Group accrued a net reinsurance premium payable of £6,574,000 (2022: £1,921,000 net reinsurance premium recovery) during the year.

In addition, HIPCC provides stop loss, portfolio stop loss and HASP reinsurance policies for the Company.

HIPCC Limited acts as an intermediary for the reinsurance products purchased by Helios. An arrangement has been put in place so that 51% of the profits generated by HIPCC in respect of the business relating to Helios will be repaid to Helios for the business transacted for the 2020 and subsequent underwriting years. The consideration paid to Nigel Hanbury of £100,000 reflects the HIPCC income that he is expected to forgo. This arrangement was terminated when Nigel Hanbury sold his shareholding and resigned as a director in HIPCC.

During 2023, the following Directors received dividends, in line with their shareholdings held:

Director	Shareholding at date dividend declared 29 June 2023	Dividend received 19 July 2023 £
Nigel Hanbury (either personally or has an interest in)	9,562,358	286,870
Andrew Christie	34,551	1,036
Arthur Manners (either personally or has an interest in)	1,197,509	35,925
Michael Cunningham (resigned 29 June 2024)	286,848	8,605
Tom Libassi (has an interest in)	13,407,000	402,210
Martin Reith	257,727	7,731
Edward Fitzalan Howard, Duke of Norfolk (resigned 19 April 2024)	382,864	11,485

26. Ultimate controlling party

The Directors consider that the Group has no ultimate controlling party.

27. Syndicate participations

The syndicates in which the Company's subsidiaries participate as corporate members of Lloyd's either directly or through MAPA's are as follows:

		Allocated capacity per year of account
Syndicate number	Managing or members' agent	2024 £000	2023 £000	2022* £000	2021* £000
33	Hiscox Syndicates Limited	15,358	15,358	15,357	15,271
218	IQUW Syndicate Management Limited	17,711	17,711	7,519	7,500
318	Cincinnati Global Underwriting Agency Limited	1,082	862	993	993
386	QBE Underwriting Limited	3,139	3,139	3,067	2,781
510	Tokio Marine Kiln Syndicates Limited	30,294	28,183	34,097	24,257
557	Tokio Marine Kiln Syndicates Limited	-	-	3,509	3,509
609	Atrium Underwriters Limited	19,528	18,421	13,714	13,168
623	Beazley Furlonge Limited	32,687	28,909	23,293	20,253
727	S A Meacock & Company Limited	2,956	2,956	2,423	2,352
1176	Chaucer Syndicates Limited	2,875	2,875	2,875	2,875
1200	Argo Managing Agency Limited	-	55	10,050	-
1699	Asta Managing Agency Limited	5,000	-	-	-
1729	Dale Managing Agency Limited	25,118	20,094	10,220	247
1796	Asta Managing Agency Limited	7,000	-	-	-
1902	Asta Managing Agency Limited	12,636	10,688	10,000	-
1925	Apollo Syndicate Management Limited	12,500	-	-	-
1955	Arch Managing Agency Limited	20,000	12,500	-	-
1966	Asta Managing Agency Limited	15,000	-	-	-
1969	Apollo Syndicate Management Limited	25,499	12,171	5,675	459
1971	Apollo Syndicate Management Limited	25,000	10,000	6,467	-
1985	Asta Managing Agency Limited	20,000	16,874	-	-
1988	Asta Managing Agency Limited	15,125	15,000	-	-
1996	Polo Managing Agency Limited	9,527	5,988	-	-
2010	Lancashire Syndicates Limited	7,338	7,338	10,642	9,999
2024	Probitas Managing Agency Limited	8,522	-	-	-
2121	Argenta Syndicate Management Limited	5,206	272	10,267	5,697
2358	Nephila Syndicate Managing Agency Limited	20,000	-	-	-
2427	Asta Managing Agency Limited	15,024	-	-	-
2454	Apollo Syndicate Management Limited	5,800	-	-	-
2525	Asta Managing Agency Limited	2,612	2,311	1,856	1,727
2689	Asta Managing Agency Limited	5,477	2,699	10,111	610
2791	Managing Agency Partners Limited	16,422	12,001	10,123	10,112
3939	Apollo Syndicate Management Limited	12,000	-	-	-
4242	Asta Managing Agency Limited	15,000	10,807	12,987	9,018
4444	Canopius Managing Agents Limited	24	21	20	182
5183	Asta Managing Agency Limited	1,727	5,000	-	-
5623	Beazley Furlonge Limited	27,001	17,672	6,894	4,770
5886	Blenheim Underwriting Limited	30,833	27,131	23,165	12,586
6103	Managing Agency Partners Limited	4,150	3,301	3,480	3,149
6104	Hiscox Syndicates Limited	10,000	32	1,774	1,839
6107	Beazley Furlonge Limited	1,550	164	1,682	1,732
6117	Ariel Re Managing Agency Limited	391	265	2,989	2,209
Total		507,112	310,798	245,249	157,295

* Including the new acquisitions in 2023.

28. Group-owned net assets

The Group statement of financial position includes the following assets and liabilities held by the syndicates on which the Group participates. These assets are subject to trust deeds for the benefit of the relevant syndicates' insurance creditors. The table below shows the split of the statement of financial position between Group and syndicate assets and liabilities:

	31 December 2023			31 December 2022
	Group £'000	Syndicate £'000	Total £'000	Group £'000	Syndicate £'000	Total £'000
Assets
Intangible assets:
- Capacity	82,436	-	82,436	59,966	-	59,966
- Positive goodwill	348	-	348	482	-	482
- Negative goodwill	(667)	-	(667)	(1,073)	-	(1,073)
Financial assets at fair value through profit or loss	70,754	217,444	288,198	73,771	152,242	226,013
Deferred income tax asset	-	-	-	-	-	-
Reinsurance assets:
- reinsurers' share of claims outstanding	60	82,948	83,008	60	80,666	80,726
- reinsurers' share of unearned premium	-	23,962	23,962	-	21,333	21,333
Other receivables, including insurance and reinsurance receivables	357	172,575	172,932	3,103	144,573	147,676
Cash and cash equivalents	40,913	25,899	66,812	10,254	15,046	25,300
Prepayments and accrued income	4,459	2,822	7,281	3,746	1,330	5,076
Deferred acquisition costs	-	32,291	32,291	-	24,991	24,991
Total assets	198,660	557,941	756,601	150,309	440,181	590,490
Liabilities
Equity
Equity attributable to owners of the Parent:
Share capital	7,795	-	7,795	7,774	-	7,774
Share premium	98,596	-	98,596	98,268	-	98,268
Revaluation reserve	24,840	-	24,840	11,350	-	11,350
Other reserves - treasury shares (JSOP and LTIP)	190	-	190	(110)	-	(110)
Retained earnings	(26,174)	34,854	8,680	2,960	(5,123)	(2,163)
Total equity	105,247	34,854	140,101	120,242	(5,123)	115,119
Insurance liabilities:
- claims outstanding	-	309,188	309,188	-	272,015	272,015
- unearned premium	-	143,610	143,610	-	114,663	114,663
Deferred income tax liabilities	22,277	58	22,335	11,228	84	11,312
Borrowings	59,055	-	59,055	15,000	-	15,000
Other payables, including insurance and reinsurance payables	6,984	63,610	70,594	157	54,736	54,893
Accruals and deferred income	5,097	6,621	11,718	3,682	3,806	7,488
Total liabilities	93,413	523,087	616,500	30,067	445,304	475,371
Total liabilities and equity	198,660	557,941	756,601	150,309	440,181	590,490

Below is an analysis of the free working capital available to the Group:

Group	31 December 2023 £'000	31 December 2022 £'000
Funds at Lloyd's supplied by:
Reinsurers	31,576	27,818
Other third party	26,995	26,421
Group owned*	69,939	73,040
Total funds at Lloyd's supplied (excluding solvency credits)	128,510	127,279
Group funds available:
Financial assets	70,754	73,771
Cash	40,913	10,254
Total funds	111,667	84,025
Less Group funds at Lloyd's	(69,939)	(73,040)
Free working capital	41,728	10,985

29. Changes arising from the conversion from IFRS to UK GAAP

The 31 December 2022 Financial Statements were prepared in accordance with International Financial Reporting Standards ("IFRSs"). The 31 December 2023 Financial Statements have been prepared in accordance with United Kingdom Accounting Standards ("UK GAAP"), including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and FRS 103 "Insurance Contracts".

Under IFRS any goodwill on bargain purchases is credited immediately to the consolidated statement of comprehensive income ("CSOCI"). Any positive goodwill is taken to the consolidated statement of financial position ("CSOFP") and subject to an annual impairment review. Under UK GAAP, both goodwill on bargain purchases and positive goodwill are taken to the CSOFP and amortised over their estimated useful life.

The Directors have concluded an estimated useful life of three years for both elements of goodwill to be amortised over, which is in line with the usual life of a Lloyd's underwriting year of account.

The prior period figures have been adjusted to reflect the changes in the accounting framework as per below:

Total other comprehensive loss	£'000
Total other comprehensive loss for the period - as originally reported at 31 December 2022 under IFRS	(1,315)
Impact of IFRS to UK GAAP conversion - bargain purchase goodwill amortisation	1,278
Impact of IFRS to UK GAAP conversion - positive goodwill amortisation	(62)
Total other comprehensive loss for the period - at 31 December 2022 under UK GAAP	(99)

Total equity	£'000
Total equity - as originally reported at 31 December 2022 under IFRS	117,178
Impact of IFRS conversion to UK GAAP - total bargain purchases goodwill booked to 31 December 2022	(4,182)
Impact of IFRS conversion to UK GAAP - cumulative bargain purchase goodwill amortisation to 31 December 2022	3,108
Impact of IFRS conversion to UK GAAP - cumulative positive goodwill amortisation to 31 December 2022	(985)
Total equity - at 31 December 2022 under UK GAAP	115,119

Goodwill intangible assets	£'000
Positive goodwill - as originally reported at 31 December 2022 under IFRS	1,468
Impact of IFRS conversion to UK GAAP - positive goodwill amortisation to 31 December 2022	(985)
Positive goodwill - as reported at 31 December 2022 under UK GAAP	482
Impact of IFRS conversion to UK GAAP - negative goodwill booked to 31 December 2022	(4,182)
Impact of IFRS conversion to UK GAAP - negative goodwill amortisation to 31 December 2022	3,108
Negative goodwill - as reported at 31 December 2022 under UK GAAP	(1,073)
Goodwill intangible asset - at 31 December 2022 under UK GAAP	(591)

Net tangible assets	£'000
Net assets less intangible assets - as originally reported at 31 December 2022 under IFRS	57,211
Impact of IFRS conversion to UK GAAP - total bargain purchases goodwill booked to 31 December 2022	(4,182)
Impact of IFRS conversion to UK GAAP - cumulative bargain purchase goodwill amortisation to 31 December 2022	3,108
Impact of IFRS conversion to UK GAAP - cumulative positive goodwill amortisation to 31 December 2022	(985)
Net assets less intangible assets - at 31 December 2022 under UK GAAP	55,152
Fair value of capacity (WAV)	59,967
	115,119
Shares in issue - on the market (Note 21)	76,218
Shares in issue - total of on the market and JSOP shares (Note 21)	77,318
Net tangible asset value per share £ - on the market	1.51
Net tangible asset value per share £ - on the market and JSOP shares	1.49

30. Events after the financial reporting period

Dividend

In respect of the year ended 31 December 2023, a final dividend of 6p per fully paid ordinary share (see Note 21) amounting to a total dividend of £4,451,000, is to be proposed at the Annual General Meeting on 28 June 2024 and paid in July 2024. These Financial Statements do not reflect this dividend payable.

Sale of subsidiaries

During the year, Helios Underwriting plc set up ten new Limited Liability Vehicles (see Note 14) of which the following have been sold post-31 December 2023:

	Sale date	Sale proceeds £
Helios LLV Nine LLP	13 March 2024	25,000
Helios LLV Three Limited	17 April 2024	5,000
Total sale proceeds		30,000

Share buy backs

The Company bought back a further 540,924 shares for a total consideration of £811,000 post-31 December 2023.

Key future dates

	Date
Date of Announcements of 2023 Final Results	30 May 2024
Ex-dividend date	6 June 2024
Record date	7 June 2024
Payment date for the recommended dividend	12 July 2024
Annual General Meeting	28 June 2024
Announcement of Interim Results	27 September 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FR PPURCAUPCGBB

Related Charts

Helios Underwriting PLC (HUW)

Most Read

Market Overview

UK 350 Risers and Fallers

Final results for the year ended 31 December 2023

Related Charts

Helios Underwriting PLC (HUW)

Most Read

Receive our daily news email

Subscribe to the latest investing news by entering your email address below

For five days a week you will get

Plus more useful investment content and occasional promotional offers.

Market Overview

UK 350 Risers and Fallers

Receive our
daily news email